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ABSTRACT 
 
  Response to range supplementation is in part driven by level of supplement 
consumed and amount of associated variation. In order to evaluate intake limiting agents 
in a self-fed dried distillers’ grain supplement (DDG), heifers (n=59) in Trial 1 were 
offered an ad libitum amount of sorghum × sudangrass hay as well as DDG containing 
either no limiter (CON), monensin (185 mg/kg; MON), or one of six additional limiters 
alone or in combination with monensin (185 mg/kg, +M). Evaluated treatments and 
initial rates consisted of sodium chloride (NACL, 10%), urea (UREA, 2%), sodium 
bicarbonate (LIME, 1.68%), DL-malic acid (MLAC, 3%), calcium propionate (CAPR, 
3%), and sodium bicarbonate plus urea (LIUR, 1.68% + 2%). Supplement intake was 
recorded daily and limiters were evaluated over three rates of inclusion, each for a 
duration of 14 d,  on the basis of intake level, intake variation (cumulative stability), and 
rate of intake change over time (temporal stability). Data was analyzed as a 7 × 2 
factorial initial 7 days of each period were removed to avoid acclimation influence. A 
baseline period was observed to ensure no inherent differences were detected. Within the 
initial rate period, limiter affected OM intake (P = 0.02) as consumption was reduced by 
NACL (P < 0.01) and tended to be lower when limited by MLAC (P = 0.14) and LIUR 
(P = 0.11). Neither monensin (P = 0.86) nor a limiter × monensin interaction were 
present. Cumulative stability was indicated that heifers consuming NACL (P < 0.01) and 
CAPR (P < 0.01) consumed supplement with greater regularity than did CONT. 
Monensin (P = 0.75) and monensin × limiter (P = 0.76) did not influence intake stability. 
Temporal stability was unaffected by limiter (P = 0.43), monensin (P = 0.69), or 
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monensin × limiter (P = 0.93). When rate of inclusion was 2 × initial rate, intake was 
affected by limiter (P < 0.01) with observations similar to the initial period.  No 
monensin (P = 0.49) or interaction (P = 0.27) effect was present. Cumulative stability 
was unaffected by limiter (P = 022), monensin (P = 0.39), or interaction (P = 0.86). 
Temporal stability was increased with monensin (P 0.05) and an interaction resulted in 
an increased rate of supplement intake change in CONT when monensin was included. 
When supplement included limiters at 4 × the initial rate, Effects on intake and 
cumulative stability by limiter were the only significant responses. Intake of LIUR, 
NACL, and MLAC were reduced relative to CONT while NACL was consumed with 
greater regularity. Trial 2 was conducted to further compare sodium chloride and DL-
malic acid as limiting agents. Each were included in a self-fed DDG supplement offered 
to steers (n=60, mean initial BW = 191 kg) at identical rates (8%, 16% 24%, and 32%) 
in addition to monensin (66 mg/kg).  Within each rate, MLAC reduced supplement 
intake more effectively than NACL while cumulative stability and temporal stability 
measures were similar among limiter and only deviated from control levels at lower 
rates.  
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CHAPTER I 
 
 INTRODUCTION AND REVIEW OF LITERATURE 
 
Necessity for supplementation of livestock diets is driven by the magnitude of 
difference between nutritional value and quantity of available forage relative to nutrient 
level required to achieve production goals. Consumption of diets based on dormant 
warm season perennial grasses often generates a need for supplemental crude protein 
and, on occasion, energy to assist in both intake and digestibility of the forage base 
(DelCurto et al., 1990). In addition to protein and energy, vitamins and other nutrients 
may be offered at predetermined target amounts to mediate nutritional deficiencies. 
Similarly, supplemented feeds may be used as carriers for ionophores and/or antibiotics 
in which delivery of appropriate dosages are contingent upon an animal consuming at 
least a target amount of feed (Kunkel et al., 2000). Overconsumption will increase cost 
of supplementation and in the case of protein, animals are unable to efficiently utilize 
excess supply. Deviation from desired intake levels can lead to variance from the 
anticipated response to a supplemental regimen. Ideally, supplemented nutrients should 
be included and consumed in amounts only necessary to meet physiological demands 
within circumstance and without excess. 
Intake variation 
Supplement intake by grazing animals is often quantified by dividing supplement 
disappearance by number of animal days. As a result of evaluating intakes as a mean 
within a group, estimation of individual intake as well as intake variation are commonly 
unreported. This is common in a large portion of previously 
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published literature.  
Individual intake variation has previously been reported as coefficient of 
variation (CV) for intake, proportion of animals in a group which consume minimal or 
no supplement (non-feeders), and proportion of animals within a group that consume a 
target amount of supplement (Bowman and Sowell, 1997). Intake variation in feedlot 
settings has commonly been assigned a residual value which is derived from the 
difference in daily intake relative to average daily feed intake over a period (Stock et al., 
1995). Factors contributing to variation include form and palatability of supplement, 
mode of delivery, feed allowance, and multiple aspects of social interaction (Bowman 
and Sowell, 1997). To date, most studies estimating intake variation of free choice 
supplements to grazing animals have been conducted with molasses based blocks and 
liquid supplements.  
Supplement form  
Supplemental nutrients may be derived from a variety of sources which include 
ethanol by-products, oilseed by-products, animal by-products, forages, minerals, and 
grains. Diversity of supplement form includes meals, loose mixes, forages, cubes, 
blocks, or liquids. Physical form of feed has been identified as a factor influencing 
intake variation (Bowman and Sowell, 1997).  
In an effort to describe differences in behavior and intake associated with form of 
supplemental protein, Garossino et al. (2003) assigned gestating beef cows either 
molasses blocks or liquid molasses. At least 70% of cows selected to receive liquid 
molasses consumed supplement on a daily basis whereas attendance to block supplement 
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ranged from 40 to 80%. No differences were detected in mean daily DM intake though 
standard deviation (SD) of daily intake was higher for the block treatment. Additionally, 
rate of consumption and was higher when supplement was in liquid form though 
duration of feeder attendance was reduced. These measures could directly relieve social 
dominance issues by increasing the proportion of time the bunk is unoccupied. Neither 
group of animals achieved the targeted mean daily intake. Before initiation of this trial, 
all cows were corralled with access to the block supplement which should eliminate 
novelty as a factor influencing variation of block intake in these observations. 
Mulholland and Coombe (1979) provided wethers grazing wheat stubble with 
mineral blocks, urea-containing mineral blocks, liquid molasses, and urea-containing 
liquid molasses. Mean CV’s were lowest for mineral blocks and highest for liquid 
molasses (44% vs. 64%) whereas values for the urea containing supplements were 
intermediate at 47% and 58% for blocks and liquid, respectively.  
In multiple experiments evaluating intake and intake variation, Dixon et al. 
(2003) offered various supplements to grazing heifers. In Experiment 1, groups were 
assigned one of four treatments: 1) restricted amount of cottonseed meal (CSM), or ad 
libitum access to 2) liquid molasses containing 74 g/kg urea (M8U), 3) salt and urea-
containing loose mineral mix (LMM), or 4) molasses blocks containing 62 and 99 g/kg, 
respectively, salt and urea (BLOCK). Intake variation expressed as CV among heifers 
within group after 10 weeks was highest for BLOCK (83%), intermediate for LMM 
(71%), and lowest for M8U and CSM (26% and 28%, respectively). Additionally, all 
heifers assigned CSM and M8U treatments consumed some supplement. Proportions of 
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non-feeders were 4% and 19% for LMM and BLOCK, respectively. These experiments 
suggest that both variation in supplement consumption and the proportion of non-
consumers a herd are expected to be greater when supplements are offered in block 
form. In Experiment 2, heifers were offered ad libitum access to one of four liquid 
molasses supplements containing low amounts of urea (74 g/kg), high amounts of urea 
(107 g/kg), monensin (120-180 mg/kg), or meat meal. No significant differences in CV 
of supplement intake were detected among the four treatments. All heifers consumed 
supplement with exception of 30% of those assigned molasses containing meat meal.  
Ducker et al. (1981) measured individual variation of block supplement intake of 
ewes from a wide range of environmental settings. Intake CV ranged from 46% to 231% 
among 15 flocks. The overall percentage of ewes not consuming any supplement was 
19%. These authors attributed differences in intake to ewe age, alternative feed 
availability, and variation between flock locations.   
Lobato and Pearce (1980) described influence of forage availability in relation to 
block supplement intake. Approximately 1200 total grazing ewes at 5 locations were 
offered molasses-urea blocks. After an initial 3 week period, 50% of ewes had consumed 
no supplement, and were removed and confined to yards where they were provided 
blocks and 350 g hay·ewe-1·d-1. After 3 weeks in confinement, percentage of non-feeders 
measured 19% and those were retained for an additional period ranging from 2 to 4 
weeks during which 88% of ewes consumed supplement. Overall individual intake of 
supplement was highly variable on both pasture (100 to 400 g·ewe-1·week-1) and in 
confinement (100 to 500 g·ewe-1·week-1).   
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In a study of supplement and forage intake by ewes grazing native winter range, 
Taylor et al. (2002) fed supplemental protein in pellet (27% CP) and block (29.3% CP) 
form. Ewes receiving pelleted feed were group fed the wheat middling-soybean meal 
based supplement at 114 g·ewe-1·d-1 whereas ewes assigned to the block treatment were 
allowed ad libitum access. Mean consumption of the two treatments were 110 and 58 
g·ewe-1·d-1 for the pellet and block supplements, respectively. Ewes receiving pelleted 
supplement had fewer non-feeders relative to those receiving block (2% vs. 35%), fewer 
individuals classified as having low-intake (5% vs. 10%), a higher proportion of animals 
consuming 51% to 150% of the mean intake (83% vs. 27%), fewer animals consuming 
excess supplement (10% vs. 28%), and a reduced CV of intake (32.0% vs. 99.5%).  
Dove and Freer (1986) provided grazing lambs individually with sunflower meal 
(SFM) in loose meal or pelleted form. Mean intake of pelleted SFM was higher (388 vs. 
335 g·lamb-1·d-1) and CV was reduced (9.9% vs. 21.2%). Similarly, Beck (1993) fed a 
self-limiting energy supplement to cattle grazing wheat pasture for four consecutive 
years. In years one and two, supplement was fed in pellet form and in meal form in years 
3 and 4. Calculated CV’s for individual supplement intake were 32% for years one and 
two (pellet) and 42.6% for years three and four (meal). 
Intake variation of oats, hay, and urea-containing molasses blocks fed to grazing 
sheep was measured in multiple experiments by Lobato et al. (1980). Observed CV for 
oat grain intake was slightly lower than that of hay (23.4% vs. 30.5%). Measure for 
block intake was much higher at 143.6%. Mean intakes (g DM·hd-1·week-1) were highest 
for hay and lowest for molasses-urea block.  
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Tait and Fisher (1996) measured intake of a 1:1 salt-commercial mineral mix and 
found wide ranges of intake by grazing steers (50 to 300 g·hd-1·d-1) with a mean intake 
of 135 g/d and CV of 41%.  
Collectively, these studies indicate that liquid supplements and dry feeds may 
deliver nutrients to grazing livestock with reduced variability relative to blocks.    
Delivery method 
Providing supplemental nutrients to grazing livestock can be achieved by 
delivering smaller amounts of feed intended for immediate consumption or by delivering 
feed in bulk that is designed or formulated to be consumed over extended periods. Hand-
feeding a smaller portion allows for tighter control of daily intake but may increase 
operational costs associated with necessity of frequent delivery (Sawyer and Mathis, 
2001). Due to feed supply in lesser amounts, hand-feeding my elevate level of 
competition and dominance issues leading to a higher proportion of non-feeders. These 
occurrences are influenced by numerous factors which include amount of accessible 
trough space, age of animals in the herd, and breed differences (Bowman and Sowell, 
1997).  
In contrast, self-feeding creates an opportunity to ameliorate costs by reducing 
frequency of travel and labor (Sawyer and Mathis, 2001). Energy and mineral 
supplements are especially suited for self-fed delivery since their efficacy is improved 
when offered daily. Benefits of providing protein in self-fed form are not as predictable 
due to flexibility in feeding frequency (Wallace and Parker, 1992; Huston et al., 1999). 
Additionally, manipulation of grazing distribution may be achieved by strategic 
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placement of stationary feeders (Bailey and Jensen, 2008). However, individual intake 
variation is expected to be higher in animals consuming supplement with this method 
(Bowman and Sowell, 1997).  
  Kendall et al. (1980) reported that heifers in confinement hand-fed a barley/SBM 
cubed supplement had individual supplement intake variation (CV) of 31%, compared to 
57% in those fed blocks of the same formulation. These results were confirmed in a 
subsequent trial, where individual intake CV’s were higher for blocks than for cubed 
supplement (82% vs. 55%, respectively).  
Feed allowance 
Feeding frequency may be drastically different depending on delivery method 
(hand-fed vs. self-fed) and, as a result, influence of feed allowance on intake variation 
must be considered. Schauer et al. (2005) reported no difference in CV values (28%) for 
protein supplement intake when cottonseed meal was offered to mature grazing cows 
daily and every sixth day (0.91 vs. 5.46 kg·hd-1·d-1). These data contradict observations 
of decreased variation when feed allowance is higher (Huston et al., 1999). When 
supplement is offered at identical daily rates, daily feedings will supply a smaller 
amount of feed per delivery. Less frequent delivery will increase feed availability for a 
period prior to depletion thereby decreasing competition and dominance issues. Schauer 
et al. (2005) measured intake and intake variation at a single point in time in this study 
and only a small portion of the population was observed. It is possible that the timing of 
data collection in this case did not provide a true indication of variability.  
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Foot et al. (1973) observed decreases in CV (36% to 16%) of intake by ewes 
when supplement allowance was increased from 100 to 453 g·hd-1·d-1. In evaluating 
block consumption by ewes, Ducker et al. (1981) identified an increase in proportion of 
non-feeders when mean flock consumption was lower and that the proportion decreased 
as mean consumption increased. Kendall et al. (1980) quantified intake variation of ewes 
provided low, intermediate, or high feed allowances offered in restricted, sufficient, or 
excess trough space and found that CV for supplement intake was inversely related to 
amount of supplement provided. Variability was further increased as trough space 
allowance was reduced. 
 Limitation of intake 
Intake limiting agents 
Diet selection by an animal is a function of nutritional demand and sensory 
acceptability of feed characteristics (Provenza, 1995, 1996 a,b). When provided with 
supplemental nutrients, unregulated consumption will often exceed amounts necessary to 
meet requirements. Supplemented nutrients generally make up a relatively small 
percentage of a ruminant’s overall diet and level of necessary intake is likely reached 
well before satiety signals are received from gut hormones and central nervous system 
activity.  
Sodium chloride is commonly used as a limiter of feed intake. Wide ranges 
(0.7%, Meyer et al., 1955; 45%, Judkins et al., 1985) have been included in feedstuffs 
with concentration adjustments occasionally needed due to increased tolerance (Kunkle 
et al., 2000).  When salt is included as a limiter, a greater intake reduction per unit of salt 
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inclusion is expected with dry feeds relative to liquids. In addition, pelleted supplements 
diminish the effectiveness of salt as a limiter compared to loose mixes and feeds in meal 
form (Kunkle et al., 2000).  
Gypsum (CaSO4) has been successfully used to limit intake, and inclusion rates 
to meet targeted intakes may be lower than levels of salt required to achieve the same 
intake (Barrentine and Ruffin, 1958) though its use is less common due to considerations 
of high sulfur content and risks of toxicity or polioencephalomalacia. Similarly, calcium 
chloride has been used to effectively limit supplement intake when included at 
concentrations lower (2.5% to 5.0%) than those shown to be effective for salt. However, 
corrosive properties are a concern and excess calcium renders the ionic halide 
undesirable in feeds not high in phosphorous content (Kunkle et al., 2000). 
Animal fat (yellow grease) included at a level of 10% in a supplement of No. 2 
corn to grazing steers limited daily supplement intake to 0.79% BW (Wise et al., 1965). 
When salt was included in corn at levels to coincide with intakes of the fat-containing 
supplement, salt levels were similar and ranged from 7 to 10%. One advantage of fat 
inclusion is increased energy supply though difficulties associated with storage and 
handling in cold weather along with scouring and possible decreases in forage digestion 
are potential disadvantages. Wise et al. (1965) observed greater ADG and supplemental 
conversion over the six month trial when supplement was limited by fat.  
Jensen (1979) measured the efficacy of numerous limiting agents in a ground 
corn supplement to cattle grazing irrigated pasture. In the first of multiple experiments, 
limiters (as a percentage of supplement) corn starch (50%), dehydrated potatoes (100%), 
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dicalcium phosphate (10%), and sodium tripolyphosphate (5%) were not effective at 
maintaining intake of supplement below a level of 1.82 kg·hd-1·d-1 after brief periods of 
adaptation.  Another experiment utilized animal fat (7.5%, 10.0%, and 15.0%), sodium 
hydroxide (1.0%, 1.5%, and 2.0%), phosphoric acid (3.0%, 4.0%, 5.0%, 6.0%, and 
7.0%), and phosphoric acid plus monensin (3.0%, 5.0%, 6.0%, and 7.0% in addition to 
110 mg per kg) and again found no significant differences in overall intake among 
treatments (P < 0.05) with intakes generally increasing with animal adaptation. An 
additional experiment was conducted using sodium hydroxide (1.0%, 1.5%, and 2.0%), 
aluminum sulfate (4.0%, 6.0%, 8.0%, and 10.0%), ammonium chloride (2.0% and 
6.0%), ammonium chloride plus ammonium sulfate (2.0% plus 6.0%), bone meal 
(8.0%), calcium chloride (4.0%), and corn gluten meal (60.0%) as intake modifiers. 
Sodium hydroxide at 2.0%, aluminum sulfate at 10.0%, and ammonium chloride at 
either 2% or 6% constrained supplement intakes to target levels. A comparison of 
aluminum sulfate plus monensin (5.0% and 10.0% plus 220 mg per kg), calcium 
carbonate plus monensin (5.0%, 10.0%, and 15% plus 220 mg per kg), and magnesium 
sulfate plus monensin (5.0% and 7.5% plus 220 mg per kg) suggested that all 
combinations successfully limited supplement intake although number of days observed 
were as few as three for some of these treatments. Measures of intake variation in this 
study are not reported.  
Urea is included in most liquid feed products and its capacity to limit intake has 
been evaluated. Barker et al. (1988) fed a 3:1 urea/superphosphate blend in a grain 
supplement fed ad libitum to steers consuming low quality hay. Concentration of the 
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blend in the supplement was increased over a period of 20 weeks in 14-d intervals from 
4% to 27%, resulting in a significant treatment effect on supplement intake with 
reductions as high as 70% compared to stable intake of supplement containing a constant 
inclusion of 2.67%.  
Schauer et al. (2004) compared the effectiveness of three intake limiters in a 
wheat middling based supplement offered in consecutive years to steers grazing native 
prairie from June through October in North Dakota. Sodium chloride (16%), ammonium 
chloride (3%) plus ammonium sulfate (2.25%), and calcium hydroxide (7%) were 
included in the supplement which was also hand fed at a rate of .50% and 0.49%  initial 
body weight (BW) during year 1 and 2, respectively. Treatments were offered in pellet 
(4.4 mm) form with the exception of the calcium hydroxide treatment which was fed in 
meal form. Data were analyzed in 28 d periods to monitor possible interaction with 
seasonal change. In year 1, no differences were detected in supplement intake which 
averaged 2.69 kg DM·hd-1·d-1 or 0.64% BW. In year 2, anionic salts failed to limit intake 
during the first two periods as intakes reached 2.05 and 2.55 kg·hd-1·d-1 compared to 
hand-fed rates of 1.64 and 1.63. Among these limiters, calcium hydroxide was most 
effective compared to other treatments during the first two periods. Steers assigned to 
control in this study were used to measure performance differences due to 
supplementation and did not receive supplement. Steers offered supplement without 
limiter were hand fed at a rate of 0.50% initial BW. Therefore, efficacy of limiters 
relative to unrestricted access of supplement is unknown. Intake of all limiter-containing 
supplements increased relative to hand-fed intake over the trial and no treatment effects 
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were present during the last two periods. As a likely indication of acclimation to the 
limiters, mean increase in supplement intake across both years from initial to final period 
was 221%, 161%, and 202% for sodium chloride, anionic salts, and calcium hydroxide, 
respectively. 
Malic acid 
Studies evaluating influence of the dicarboxylic organic acids fumaric acid and 
malic acid in ruminant diets to date have primarily pertained to their role in 
methanogenesis. Newbold et al. (2005) suggests that propionate precursors may function 
as electron sinks competing with methanogens for ruminal H2. Published results have 
highly variable, ranging from no effect (Beauchemin and McGinn, 2006; McCourt et al., 
2008) to reductions in methane production as high as 75% (Wallace et al., 2006). Use of 
these propionate precursors to reduce methanogenesis may also influence feed intake. 
Multiple studies present evidence of reduced CH4 emissions/day but not per kg DMI, 
and attribute these findings to reductions in total DMI when diets contain various levels 
of organic acids (McGinn et al., 2004; Beauchemin and McGinn, 2006; Molano et al., 
2008).  
Foley et al. (2009) observed linear decreases in total DMI by including malic 
acid in a supplement fed to heifers (P < 0.001) and steers (P = 0.002). When heifers 
were subjected to 3 levels of malic acid inclusion (0%, 3.5%, and 7.5%), a linear 
decrease was also observed in supplement (P < 0.001) and silage (P = 0.01) intake. 
Malic acid inclusions of 0%, 2.5%, 5.0%, and 7.5% in supplement fed to steers 
generated quadratic reductions to silage consumption (P = 0.003) and total DMI (P < 
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0.001). A tendency for a quadratic effect (P = 0.07) was observed for supplement intake. 
In each case, DMI was affected by initial increment with no other reductions at 
subsequent levels.  
Wallace et al. (2006) observed intake of an ad libitum concentrate diet by lambs 
of 0.3 kg and 0.2 kg lower relative to a control group (P < 0.10) when fed either 100g/kg 
concentrate of fumaric acid or 117g/kg of encapsulated fumaric acid, respectively. 
Similarly, Molano et al. (2008) observed reduced DMI when wethers were fed ground 
lucerne with fumaric acid inclusions of 4%, 6%, 8%, and 10% of DM. Reductions in 
DMI (kg/d) and CV’s for DMI relative to control were 0.04 and 5.94%, 0.27 and 
18.18%, 0.21 and 19.28%, and 0.22 and 17.07%, respectively. These results appear to be 
quadratic though polynomial contrasts were not reported.  
Conversely, numerous studies have produced no evidence of malic acid influence 
on feed intake (Kung et al., 1982; Martin et al., 1999; Montano et al., 1999, Carro et al., 
2006; Wang et al., 2009). However, these studies included organic acids at rates much 
lower relative to other studies where effects were observed. Of these studies finding no 
influence on voluntary intake, the highest inclusion rate was 2.66% DM (Montano et al., 
1999).  
Monensin 
 Manipulation of rumen metabolism has been the focus of extensive research due 
to possible performance increases associated with improved fermentation. Monensin 
sodium is a commonly used feed additive ionophore (Schelling, 1984). A primary 
advantage of feeding monensin is a shift in volatile fatty acid (VFA) production in which 
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propionate is increased at the expense of acetate (Richardson et al., 1976). As a result, 
energetic efficiency is improved due to the role of propionate in both gluconeogenesis as 
well as direct oxidation via the citric acid cycle. Schelling (1984) summarized monensin 
influence on ruminants and classified its biological effects into modification of VFA 
production, change in feed intake, change in gas production, modified digestibility, 
protein utilization, rumen passage, and other effects. 
Muller et al. (1986) provided results of multiple trials in which monensin was 
included with a target consumption of 200 mg·hd-1·d-1 (actual 177 mg·hd-1·d-1) in self-
fed energy supplements to grazing cattle on various types of pasture. Supplements were 
limited by salt and level of inclusion (5% to 36%) was adjusted to maintain desired 
intake levels in each trial. Pooled data indicate that cattle consuming monensin had 
higher average daily gain (ADG; P < 0.01) and consumed 18.2% less supplement than 
control cattle. In addition, salt levels were lower and less frequent adjustments to salt 
level in order to maintain intake were required in groups fed monensin. In the trials 
included, means both minimum and maximum levels of salt required to maintain 
targeted intakes were reduced by monensin inclusion by 49.6 and 30.4%, respectively. 
These data indicate that monensin may serve as a limiter of supplement intake without 
sacrificing gain performance.  
Potter et al. (1986) observed similar effects when monensin (200 mg hd-1·d-1) 
was fed in supplements to steers fed forage based diets in confinement. In trials where 
feed intake was measured, pooled values for cattle fed monensin were lower (3.1%, P < 
0.01) than for control groups. Improvements in ADG and feed:gain were also realized (P 
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< 0.01). Paisley and Horn (1996) reported monensin (165 mg/kg) reduced intakes of a 
self-fed energy supplement by steers grazing wheat (P < 0.001; .64 and 2.29 kg·hd-1·d-1, 
respectively). Catsaounis et al. (1980) top-dressed the feed of bulls with a mineral 
supplement with or without monensin and observed reduced total daily feed intakes 
(8.9%) by bulls consuming monensin. Weight gain and feed conversion were increased 
(1.8% and 11.3%, respectively). Intake of corn-based supplement by finishing heifers on 
ryegrass was 25% less (P < 0.05) when the supplement contained 66 mg/kg monensin 
(Utley et al. 1978). No difference was observed in ADG between treatment groups. 
Jensen (1979) found that supplement intake was only temporarily held to target levels 
when monensin was included in a corn supplement at concentrations of 220 mg/kg, 
330mg/kg, and 440 mg/kg. Intakes increased after cattle acclimated to treatments.  
Dried distillers' grains 
Supplements to grazed forage systems are provided to increase individual animal 
performance and their value is estimated by the extent of increased production as a result 
of improved nourishment. Due to relatively high crude protein and energy density levels, 
dried distillers’ grains may be an ideal supplement to dormant warm season forages.  
Roughly two-thirds of the protein content within DDG is undegradable (UIP, by-
pass) by ruminal microbes (NRC, 1996). Though lower levels of animal production may 
be sustained from microbial crude protein alone, DDG as a supplement to grazing 
ruminants has the capacity to facilitate higher levels of production by contributing a 
considerable proportion of protein to the small intestine. MacDonald et al. (2006) 
measured daily gains when an alternate UIP source was supplemented at a level to 
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provide the amount of bypass protein obtained from DDG. Results indicated that gain 
response was only about 40% of that realized with DDG supplementation on growing 
forages. Implications are that about one third of gain increases observed with DDG 
supplementation may be due correcting microbial protein deficiencies. 
As an added convenience, fat levels in DDG render the co-product a potential 
supplemental energy source supplying 120% the energy value of corn. The fiber in DDG 
is highly digestible and in combination with fat levels, increases value as a viable energy 
source (Lodge et al., 1997). Conventional grain-based energy supplements have reduced 
fiber digestibility of low and moderate quality forages when offered at levels up to 0.9% 
BW (Chase and Hibberd, 1987). Due to removal of starch during production of 
distillers’ by-products, reduced competition between amolytic and cellulolytic microbes 
are expected, thus reducing the occurrence of negative associative effects.  
Positive associative effects have been observed with use of supplemental DDG. 
Neither inclusion of supplemental UIP using corn gluten meal nor fat via corn oil in a 
supplement at levels contained within DDG resulted in observed ADG by heifers offered 
a DDG supplement on bromegrass pastures (MacDonald et al. 2007). This indicates that 
the combined attributes of proportional UIP of total crude protein and fat in DDG 
contribute the uniqueness of DDG and its potential to provide performance increases in 
grazing ruminants. 
Numerous measures of performance increase and forage substitution are 
available. Heifers consuming various forage qualities supplemented with DDG up to 
0.95% BW had increased overall ADG and consumed less forage per unit increase of 
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DDG intake (MacDonald and Klopfenstein, 2004; Morris et al., 2006). Luepp et al. 
(2009) fed increasing levels (up to 1.2% BW) of DDG to steers fed moderate quality 
forage and observed linear decreases in hay OMI and linear increases in both DDG and 
total OMI. Additionally, Loy et al. (2007) offered a DDG supplement both daily (0.4% 
BW) and on alternate days (0.8% BW) to heifers consuming grass hay (8.0% CP) and 
reported similar decreases in hay DMI and increases in total DMI.  
From an economic perspective, value of DDG as a supplement can be derived 
from the sum of values attributed to increased performance and reduction in forage 
consumption. At the very least, DDG should be considered a viable option in selection 
of a highly valuable forage supplement. Allocation of DDG worth between forage 
replacement and animal performance is highly variable. In a trial by Morris et al. (2006), 
89.1% of DDG value was attributed to improved animal performance with DDG 
supplement to low quality forages being 3.3 percentage units higher than the value on 
high quality forage (90.8% vs. 87.5%) when fed at identical rates. This result would be 
consistent with expectations due to greater potential for nutritional mediation in lower 
quality forage conditions. MacDonald and Klopfenstein (2005) grazed heifers on 
bromegrass and estimated that DDG supplement worth was primarily a factor of forage 
replacement (62.4%). In regards to DDG value partitioning, a portion of the 
discrepancies between these two studies may be attributed to inconsistencies in assigned 
value of grazed forage and higher rates of supplementation.  
Market price of DDG is typically determined by the current price of conventional 
protein and energy feeds, soybean meal and corn. Common estimates of cost relative to 
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corn range from 70% to 90% on a DM basis. These prices are suspended by costs of 
processing that included drying but are lower than wet products due to reduced freight as 
a result of deliverable dry matter.  
Published intake ranges of DDG up to 1.0% BW are numerous; however, 
estimates of unregulated DDG intake are elusive. Though demonstrations of forage 
substitution have been reported at various supplement rates, limitations to dietary 
inclusion exist due to sulfur concentration and, in the case of cattle fed in confinement, 
issues with physically effective fiber (peNDF) and fat levels when used as the primary 
energy source. Published rates of supplemental inclusions are as high as 3.6 and 3.5 
kg·hd-1·d-1 for pasture and pen-fed studies, respectively (Griffin et al., 2009). Due to 
difficulties associated with measuring forage consumption on pasture, estimates from 
pen studies are primarily used to quantify forage intake as a response to supplement 
intake.  
Despite enhancement of supplement potential due to nutrient profile, wide 
variances in concentration of other nutrients have been observed. Belyea et al. (1989) 
stated that CP% of DDG can range from 27% to 35%. Mean concentrations and CV of 
CP% (30.2%, 6.4%) and crude fat (10.9%, 7.8%) published by Spiehs et al. (2002) were 
similar to estimates of concentration and variance reported by Belyea et al. (2004) who 
sampled DDG over a five year period. These wide ranges may contribute to difficulty in 
formulating supplements or estimating allowances to meet animal demands. Primary 
sources of nutrient variation have not been positively identified. Belyea et al. (2004) 
analyzed corn supply to an ethanol plant and reported no correlation between 
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components of corn and DDG thus suggesting that variation is likely not associated with 
variability of nutrient profiles in sourced corn but instead inconsistencies in ethanol 
processing.  
Along with issues in nutrient variability, physical structure is a characteristic of 
concern that may influence the application in feeding systems. Analysis of DDG particle 
form identifies some properties of concern in effectively delivering the feed to grazing 
animals (Rosentrater, 2006). Issues of binding in storage bins and bulk feeders are less 
severe with dried products relative to wet feeds; however, residual moisture, fat 
concentrations, and shape and structure of particles contribute to occasional issues 
(Behnke, 2007). Coincidentally, attributes that yield DDG a desirable feedstuff also 
complicates its potential to conform as a consistent pellet. Two of the primary examples 
are reduced starch, which serves to bind particles, and a higher level of hydrophilic 
content due to oils that reduce bonding capability (Behnke and Beyer, 2002).  
Metaphylaxis and implants 
Metaphylaxis 
Metaphylactic antimicrobial therapy is a mass application practice intended to 
mitigate risk and implications of disease outbreak within a group. Treatment is usually 
administered upon arrival as cattle typically break within the first few days. Despite 
costs of blanket treatments, mass drug application may be desirable due to possible 
occurrences of subclinical illness or caretaker failure to identify symptoms (Nickell and 
White, 2010). In a compilation of studies evaluating metaphylactic use in arriving feeder 
cattle, Wileman et al. (2009) reported improved (P < 0.01) morbidity treatment and 
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mortality rates of 47% and 53%, respectively. This same analysis also reported an 
improved ADG of 0.11 kg in cattle subjected to metaphylaxis compared to untreated 
cattle. Step et al. (2007) evaluated single or multiple dose administration and observed 
response to treatment was improved when cattle were dosed a single time but that bovine 
respiratory disease morbidity was less severe when cattle were treated once on arrival 
and a second time eight days later.  
Implants 
Anabolic growth promoting agents improve gain performance of stocker cattle in 
a consistent manner by 10 to 15% and have the potential to increase response to 
supplementation programs (Kuhl, 1997). McMurphy et al. (2009) measured influence on 
ADG by multiple implant types with multiple supplements by steers grazing summer 
pasture. Implantation generated increased ADG (7.7%, P < 0.01) over the entire 126-d 
grazing period with no differences observed among implant types. Interaction of implant 
and supplement type was not significant though steers consuming a dried distillers’ 
grain supplement had higher ADG relative to steers consuming cottonseed meal due to 
increased energy utilization. Despite absence of this interaction in the presence of 
increasing plane of nutrition, other studies suggest expectations of performance as 
influenced by implantation should be expected to increase as quality and availability of 
basal diet improve (Selk et al., 2006).  
 Sufficient evidence that DDG is a viable option for range supplementation to 
grazing cattle is available in previous literature. However, there is uncertainty of 
effective delivery methods other than hand feeding. Further evaluation of intake control 
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agents with an emphasis on novel intake limiters and their combinations with monensin 
may lead to an increase in value of the by-product if its delivery to can be reliably 
predicted.  
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CHAPTER II 
 ASSESSING THE EFFECTIVENESS OF INTAKE CONTROL AGENTS IN A 
SELF-FED SUPPLEMENT BASED ON DRIED DISTILLERS’ GRAINS 
All animal care and use procedures described in this protocol were approved by 
the Texas A&M University Animal Care and Use Committee (AUP 2009-239). 
Research was conducted at the Texas A&M AgriLife McGregor Research Center outside 
of McGregor, TX during the winter of 2010/2011. 
Introduction 
 Dried distillers’ grains can be provided to grazing cattle as a source of both 
supplemental crude protein and energy from fat and highly digestible fiber (Lodge et al., 
1997; MacDonald et al., 2007). Numerous studies have documented intake and animal 
performance responses using hand fed supplemental DDG at various consumption rates 
(MacDonald and Klopfenstein, 2004; Morris et al., 2006; Luepp et al., 2009); however, 
previous literature is void of efforts to quantify intake of supplemental DDG provided ad 
libitum. Method of supplement delivery is expected to influence precision with which 
nutrient mediation is achieved (Bowman and Sowell, 1997). Providing a supplement to 
grazing cattle free choice will often result in higher variation in supplement intake and 
thus diminish efficacy (Kendall et al., 1980). Therefore, value of DDG as a supplement 
may be enhanced if methods to accurately control intake are identified.  
 Traditionally, sodium chloride has been included in range supplements for 
purposes of intake restriction. Ranges of inclusion are wide and necessary formulations 
have been as high as 45% (Judkins et al., 1985). Kunkle et al. (2009) noted that frequent 
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formulation adjustments may also be needed due to acclimation. Exploration of 
alternative agents using criteria of intake and variation of intake are warranted. Muller et 
al. (1986) found that inclusion of monensin in an energy supplement offered to cattle not 
only served to limit intake, but also improved longevity of limiter effectiveness.  With 
this reasoning, our objective was to evaluate potential intake limiting agents included at 
multiple rates both alone and in combination with monensin at in a self-fed DDG 
supplement. Criteria of evaluation included supplement intake, variation in daily 
supplement intake, and stability of supplement intake over time. 
Materials and methods 
Fifty-nine Angus-sired, weanling heifers (191 kg mean initial BW) were used to 
evaluate the effectiveness of potential intake limiting agents with and without monensin 
in a self-fed corn distillers’ grains (DDG) supplement. Heifers were stratified by 
weaning weight and randomly assigned (2 heifers per pen) to pens equipped with four 
Calan gates (American Calan, Inc., Northwood, NH). Each heifer was fitted with keys 
enabling access to two Calan gate feed bunks, one containing chopped hay and the other 
containing supplement. Initially, heifers were provided 1 kg/d of DDG and ad libitum 
access to sorghum x sudangrass hay in the adjacent bunk until acclimated to the feeding 
system and bunk assignments. 
 Following acclimation, heifers were provided with ad libitum access to DDG 
and hay. Refusals of supplement were weighed each morning prior to feeding for four 
days preceding application of treatments to determine baseline intake of DDG and hay 
by each animal. Heifers were weighed on the first day that treatments were applied. 
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Treatments were randomly assigned to pen and bunk. Treatments were arranged 
as a 7 X 2 factorial with 6 limiting agents plus a negative control offered alone or in 
combination with monensin (185 mg·kg-1·suppl.-1).  Limiting agents were: no limiter 
(CONT), salt (NACL), urea (UREA), limestone (LIME), malic acid (DL-malic acid, 
food grade, Baddley Chemicals, Inc., Baton Rouge, LA; MLAC), calcium propionate 
(NutroCal, Kemin AgriFoods North America, Des Moines, IA; CAPR), and limestone 
with urea (LIUR). Supplements were prepared in bulk each week by combining limiting 
agent and DDG in a portable rotary mixer for a duration of at least five minutes and until 
visual appraisal of consistent particle distribution was achieved. Treatments were 
sampled from mixer immediately after manufacturing of each 45 kg batch and 
composited within period. 
Treatments were applied during three sequential experimental periods with 
increasing rates of limiter inclusion among periods (Table 1). Period durations were 14, 
15, and 13 days for periods 1, 2, and 3, respectively. Animals and treatments were not 
re-randomized in subsequent periods to avoid the influence of novelty on consumption 
responses. Additionally, rates were not randomized among periods to avoid creation of 
aversions in earlier periods that would unduly influence responses in later periods. Thus, 
rate and period were purposefully confounded, and data from each period were analyzed 
separately to make comparisons among limiters within experimental periods.  
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Table 1. Limiting agent inclusion rate by period in a self-fed dried distillers’ grain supplement 
fed to yearling heifers (% inclusion in supplement, as-fed basis) 
 Treatment1,2 
Item CONT NACL UREA LIME MLAC3 CAPR4 LIUR 
Baseline Control 0 0 0 0 0 0 
Period 1 Control 10 2 1.68 3 3 1.68 + 2 
Period 2 Control 20 4 3.36 6 6 3.36 + 4 
Period 3 Control 40 8 6.72 12 12 6.72 + 8 
1Treatments were salt (NACL), urea (UREA), calcium carbonate (LIME), malic acid (MLAC), 
calcium propionate (CAPR), and calcium carbonate plus urea (LIUR). 
2Treatments were fed alone or in combination with monensin (+M; 2.5%) 
3Kemin AgriFoods North America, Inc., Des Moines, IA. 
4Baddley Chemicals, Inc., Baton Rouge, LA. 
 
 
 
All animals had continuous, ad libitum access to chopped sorghum x sudangrass 
hay (Table 2). Hay availability was monitored daily during supplement feeding and 
supplied on an individual basis when necessary. During each experimental period, 
supplement refusals were weighed at 0700 daily.  Supplement was then added to replace 
disappearance from previous day plus 0.91 kg of additional supplement to ensure ad 
libitum access. Every seventh day, accumulated refusals of both supplement and hay 
were sampled and discarded then replaced with fresh feed to mimic weekly 
replenishment of a bulk feeder in practice. Refusal samples collected every seventh day 
were composited by animal and within period for DM and OM measure.  
Samples of supplements, hay, and refusals of both were placed in a forced-air oven at 
60ºC for 96 h to determine DM. Samples were ground to pass through a 1 mm screen of 
a Wiley mill (Thomas Wiley, Laboratory Mill Model 4, Thomas Scientific Co., 
Philadelphia, PA) and analyzed for ash, NDF, ADF, and CP. Organic matter was 
calculated from ash content of a 0.5 g sample placed into a muffle furnace (500º C) for 8 
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hours.  Fiber content was estimated using ANKOM 200 Fiber Analyzer (ANKOM 
Technologies, Inc., Macedon, NY). Crude protein values were derived using Dumas 
combustion (Rapid-N-Cube, Elementar America, Inc., Mt. Laurel, N.J.). Nutrient 
composition of treatments and hay by period are provided in Tables 2, 3, and 4. 
 
 
Table 2. Initial rate period nutrient composition of treatment1,2 in a self-fed dried distillers’ 
grain supplement and sorghum x sudangrass hay.  
 Nutrient 
Item DM% OM% NDF% ADF% CP% 
CONT 90.24 94.03 43.03 12.39 27.80 
NACL 91.48 85.71 38.54 10.59 26.59 
UREA 90.88 93.90 43.62 11.26 29.79 
LIME 91.15 92.75 44.33 11.94 29.52 
MLAC 91.19 94.82 43.64 12.39 27.61 
CAPR 86.92 91.61 42.85 10.80 24.97 
LIUR 90.36 93.27 46.18 13.70 28.74 
CONT+M 90.90 94.06 43.54 10.44 27.80 
NACL+M 91.34 85.21 41.07   9.99 27.78 
UREA+M 90.11 94.25 41.63 11.56 23.90 
LIME+M 89.84 91.89 42.94 12.47 31.30 
MLAC+M 90.90 93.14 45.64 14.45 27.75 
CAPR+M 91.34 92.58 39.41 12.02 27.22 
LIUR+M 90.76 90.70 41.39 12.40 27.43 
Hay 93.77 91.02 56.79 28.45   9.94 
1Treatments were salt (NACL), urea (UREA), calcium carbonate (LIME), malic acid (MLAC), 
calcium propionate (CAPR), and calcium carbonate plus urea (LIUR). 
2Treatments were fed alone or in combination with monensin (+M) 
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Table 3. 2 × initial rate nutrient composition of treatments1,2 in a self-fed dried distillers’ 
grain supplement and sorghum x sudangrass hay.  
 Nutrient 
Item DM% OM% NDF% ADF% CP% 
CONT 89.10 94.44 43.65 13.57 26.25 
NACL 91.09 73.68 37.55 9.77 22.75 
UREA 90.80 94.49 43.02 11.92 32.92 
LIME 90.92 88.79 39.98 12.02 24.08 
MLAC 91.33 95.17 41.22 10.29 25.50 
CAPR 91.44 90.70 39.58 10.77 27.10 
LIUR 90.08 90.33 37.48 10.54 31.06 
CONT+M 89.73 94.44 46.06 10.08 24.67 
NACL+M 92.18 76.29 31.62 7.92 22.78 
UREA+M 89.98 94.28 40.33 11.01 34.80 
LIME+M 89.18 90.25 39.95 9.42 25.55 
MLAC+M 92.12 94.14 37.12 12.11 26.79 
CAPR+M 91.64 92.09 40.64 11.75 24.62 
LIUR+M 88.88 90.73 41.92 10.76 29.87 
Hay 95.95 90.51 65.55 39.66 10.78 
1Treatments were salt (NACL), urea (UREA), calcium carbonate (LIME), malic acid (MLAC), 
calcium propionate (CAPR), and calcium carbonate plus urea (LIUR). 
2Treatments were fed alone or in combination with monensin (+M) 
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Within observation periods, calculated standard deviation of supplement intake 
(cumulative stability), rate of change in supplement intake (temporal stability), 
coefficient of variation of supplement intake, and daily hay intake were evaluated along 
with direct measure of supplement intake. Temporal stability, or the directional change 
in daily intake over time, was quantified by regressing individual intakes within period 
using day as a first order predictor.  After initial analysis, second-order regressions of 
supplement intake on time were estimated for each heifer. The derivative of estimated 
equations were set to zero and solved to determine a critical value of the predictor. A 
secondary analysis was conducted of data including days after the mean critical value 
Table 4. 4 × initial rate nutrient composition of treatments1,2 in a self-fed dried distillers’ grain 
supplement and sorghum x sudangrass hay. 
 Nutrient 
Item DM% OM% NDF% ADF% CP% 
CONT 91.10 93.85 40.94 11.07 27.66 
NACL 94.07 57.31 21.35   4.18 14.98 
UREA 89.76 93.11 40.48 10.90 37.49 
LIME 91.14 88.79 40.31   9.79 28.04 
MLAC 90.39 94.16 39.87   9.63 25.85 
CAPR 89.60 88.32 38.42   9.22 24.71 
LIUR 89.89 85.65 38.83   8.24 35.80 
CONT+M 90.78 93.79 38.17   9.10 27.36 
NACL+M 94.90 45.74 22.16   4.61 13.03 
UREA+M 89.15 93.98 42.43 40.48 36.13 
LIME+M 91.64 87.22 37.45   8.95 26.97 
MLAC+M 91.91 94.73 38.72   9.65 25.82 
CAPR+M 91.98 88.48 36.36   8.62 22.42 
LIUR+M 89.26 91.67 36.55 10.22 37.71 
Hay 94.66 90.29 56.26 27.65 10.42 
1Treatments were salt (NACL), urea (UREA), calcium carbonate (LIME), malic acid (MLAC), 
calcium propionate (CAPR), and calcium carbonate plus urea (LIUR). 
2Treatments were fed alone or in combination with monensin (+M) 
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among treatments, in order to remove days within each period potentially contributing 
variance as a result of acclimation. All regression parameters were estimated using 
regression procedures of SAS 9.2 (SAS Inst. Inc., Cary NC). Daily hay intake was 
calculated by dividing weekly disappearance by 7. 
Within periods, response variables (mean supplement intake, mean hay intake, 
cumulative stability of supplement intake, and temporal stability of supplement intake) 
were analyzed as a completely randomized design with a 7 × 2 factorial treatment 
arrangement using the mixed models procedure of SAS 9.2. Limiter type, monensin 
inclusion, and their interaction were included as effects in the model. Mean responses for 
each limiter were compared to the control treatment using F-protected t-tests. Pairwise 
comparisons among limiters were not performed. Effects were considered statistically 
significant when P < 0.05. Effects are discussed as tendencies or trends when 0.05 < P < 
0.15. 
The effect of inclusion rate of limiters on response variables was evaluated using 
regression procedures of SAS v 9.2, where inclusion rate and inclusion rate squared were 
included as predictor variables in the model. 
Results and discussion 
Limiting agents evaluated were selected based on either potential to compliment 
the nutritional profile of DDG, industry wide acceptance, or novelty. Limestone was 
chosen and included at an initial rate to achieve a 2:1 calcium to phosphorous ratio for 
the DDG-based supplement (NRC, 1996). Waller et al. (1980) observed increased 
protein utilization when urea was included in a DDG supplement due to complimentary 
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protein attributes of urea (DIP) relative to protein composition of DDG.  A combination 
of limestone and urea was evaluated as an ideal complement to the composition of DDG. 
Sodium chloride is easily accessible with a well-documented ability to limit intake in 
self-fed applications. Calcium propionate salts may have a similar effect on palatability. 
Calcium propionate is sour (acidic), provides some calcium to the mixture and may 
serve as a source of additional energy in the supplement, in contrast to entirely inorganic 
ingredients. Finally, malic acid was evaluated due to its intake reduction characteristics 
in limited application (Foley et al., 2009) and its use in flavoring applications in the food 
industry. Monensin was included in the design based on prior observations of 
supplement intake reduction (Muller et al., 1986) and its effect on apparent energy value 
of diets. 
Baseline 
 
Supplement intake. Mean daily supplement DM and OM intakes during the 
acclimation period were 3.03 kg and 2.83 kg, respectively. There were no differences in 
OMI (P = 0.56) among heifers assigned to receive different limiter treatments, nor 
among heifers assigned to receive treatments with or without monensin (P = 0.92). 
Additionally, no limiter × monensin combinations (P = 0.84) were detected. These 
expected results confirm similarity among heifers at the initiation of the trial, and that 
subsequent differences in consumption were likely not the result of individual variation.  
Cumulative stability. Measures of supplement OM intake variability were not 
different among treatments during the acclimation period (P = 0.93). Neither inclusion 
of monensin (P = 0.81) nor combinations of assigned limiter × monensin (P = 0.91) 
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affected intake variability. Mean supplement OMI variability was 0.86 kg. As expected, 
CV for OMI was not affected by limiter (P = 0.95) or monensin (P = 0.83). In the 
absence of agents, no limiter × interaction was detected (P = 0.90). Results of analysis 
on cumulative stability in this period indicate that differences in subsequent periods are 
not due to individual response to DDG. 
Temporal stability. Changes in supplement OM intake over the first four days of 
collection were not different among treatment groups (P = 0.60). Numerically, OM 
intake decreased daily by 0.11 kg. Neither monensin (P = 0.37) nor combination of 
limiter × monensin (P = 0.60) affected temporal change.  
 Hay intake. Consumption of forage was not different among treatment 
assignments (OMI, P = 0.56) and no differences were detected between groups receiving 
treatments with or without monensin (P = 0.92). As expected, no limiter × monensin 
combination was present (P = 0.84). Baseline OM intake of hay among all treatment 
groups was 0.99 kg/d. 
Treatment Period 1: Initial rate 
 Supplement intake. The degree by which voluntary consumption of a limiter-
containing feed is reduced relative to that of an unadulterated feed of the same base is 
most indicative of a limiting agent’s potential. When intake limiters in this study were 
included in supplement at the initial rates, OM intakes among treatment groups were 
affected (P = 0.02). Relative to CONT, NACL reduced supplement OMI (P < 0.01); 
MLAC (P = 0.14) and LIUR (P = 0.11) tended to reduce supplement OMI compared to 
DDG alone. As a percentage of BW, this level of salt intake (0.14%) is consistent with 
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typical inclusion levels of 0.05 to 0.15% BW when used as a limiter (Kunkle et al. 
2000). Addition of monensin did not influence supplement OM intake (P = 0.86), and no 
limiter × monensin combination effects on supplement OM intake were observed (P = 
0.66). Supplement intake means and variation measures for limiter treatments within the 
initial rate period are shown in Table 5. 
Based on estimates of the critical value (days) required to achieve stable intake 
after introduction of the supplement, a separate analysis was conducted over the final 7 d 
of the measurement period. Using this truncated data, mean supplement OMI was 
diminished by NACL (P = 0.02) relative to CONT, with a similar response observed in 
heifers provided MLAC (P = 0.05). No other treatments effectively reduced supplement 
intake levels from those of heifers assigned CONT. Addition of monensin had minimal 
effect on supplement OMI (P = 0.34) during the last 7 d of the first experimental period 
and no limiter × monensin interaction was observed (OMI, P = 0.60). 
Published reports of ad libitum intake levels of DDG are not available. 
Consumption levels observed in this experiment were much higher than expected. Over 
the final 7 d of the initial treatment period, and at an initial BW of 191 kg, heifers 
provided unregulated supplement consumed 2.5 % of their BW as DDG, which is 
substantially higher than provisions in previous research which typically peaked near 
1.5% BW (Griffen et al., 2009). Based on these high levels of unrestricted consumption, 
effective means to control intake are essential to the use of DDG as a self-fed source of 
supplemental nutrients. 
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Table 5. Period 1 intake of hay and supplement, and supplement intake variance measures of a self-fed dried distillers’ grain supplement fed 
to growing beef heifers 
 Treatment1     
 CONT CAPR LIME LIUR MLAC NACL UREA SE L2 M3 L × M4 
 ---------------------------------------------------------------------DMI, kg/d---------------------------------------------------------------------- 
14 d            
   Hay Intake 1.50 1.97 2.00a 1.95 2.33a 2.66a 1.56 0.18 0.01 0.16 0.51 
   Supplement Intake 4.27 3.86 4.01 3.65 3.57 2.64a 4.11 0.34 0.03 0.87 0.55 
   Cumulative stability
 
1.14 1.20 1.35 1.29 1.04 1.41 0.97 0.14 0.21 0.19 0.17 
   Temporal stability
 
0.15 0.22 0.23
b 
0.20 0.05
b 
0.25
a 
0.11 0.04 0.01 0.04 0.08 
last 7 d            
   Hay Intake 1.12 1.54 1.60 1.67
a
 2.11
a
 2.05
a
 1.28 0.20 0.01 0.05 0.12 
   Supplement Intake
 
4.80 4.74 4.86 4.33 3.66
b 
3.63
a 
4.49 0.41 0.15 0.34 0.48 
   Cumulative stability 1.04 0.65a 1.20 1.17 0.97 0.69a 1.00 0.12 0.01 0.67 0.74 
   Temporal stability 0.26 0.12 0.31 0.28 0.22 0.19 0.15 0.07 0.45 0.63 0.92 
----------------------------------------------------------------------OMI, kg/d--------------------------------------------------------------------- 
14 d            
   Hay Intake 1.39 1.80 1.84a 1.78 2.13a 2.43a 1.43 0.16 0.01 0.16 0.49 
   Supplement Intake 4.09 3.60 3.75 3.40 3.43 2.52a 3.94 0.31 0.02 0.86 0.66 
   Cumulative stability 1.06 1.10 1.24 1.18 0.96 1.19 0.90 0.12 0.35 0.17 0.13 
   Temporal stability 0.14 0.20 0.22b 0.19 0.05b 0.22b 0.10 0.03 0.01 0.04 0.10 
last 7 d            
   Hay Intake 1.05 1.41 1.48 1.53
a
 1.93
a
 1.87
a
 1.18 0.18 0.01 0.05 0.11 
   Supplement Intake 4.61 4.42 4.55 4.03 3.55a 3.38a 4.32 0.37 0.12 0.34 0.60 
   Cumulative stability 0.96 0.59a 1.09 1.06 0.89 0.55a 0.92 0.11 0.01 0.75 0.76 
   Temporal stability
 
0.23 0.11
 
0.28 0.26 0.20 0.15
 
0.14 0.07 0.43 0.69 0.93 
1Treatments were: control (CONT; no limiter); salt (NACL, 10%); urea (UREA, 2%); calcium carbonate (LIME, 1.68%); malic acid (MLAC; 3%), 
calcium propionate (CAPR, 3%), and calcium carbonate plus urea (LIUR, 1.68 + 2%) 
2Limiter effect 
3Monensin effect 
4Limiter × monensin 
aWithin a row, means with a superscript differ from CONT at P < 0.05 
bWithin a row, means with a superscript differ from CONT at P < 0.15
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Effects of malic acid on total dietary DMI in this study were similar to previous 
observations where included at a similar rate. Foley et al. (2009) observed a total DMI 
reduction of 4% when inclusion was 2.5% relative to a control. However, concentrate 
was pelleted and fed mixed with forage - both of which may have contributed to 
depressed efficacy of malic acid as a limiter. Comparisons of total DMI between these 
studies as opposed to supplement/concentrate alone are warranted due to the fact that, in 
the referenced study, feed was mixed when offered to achieve a targeted 60:40 
concentrate to forage ratio and was then separated at weigh back to quantify fractions. In 
the current study, when malic acid was included at 3% supplement intake was reduced 
by 2.5%; whereas including 10% NACL reduced supplement intake by 4.1% relative to 
CONT. Foley et al. (2009) achieved a slightly greater reduction in total DMI likely due 
to the fact that the malic acid inclusion was 2.5% of the total diet whereas our inclusion 
rate was limited to DDG alone. Calculated inclusion of malic acid as a proportion of 
total DMI would have been 1.90% during the last 7 d of the initial period. 
Although the objective of this study is to evaluate limiting agents independently 
against a control, it is notable that MLAC was more than two (2.02) times as effective as 
NACL at reducing total DMI per unit of inclusion. 
Cumulative stability.  Supplementation response may be influenced by variability 
in consumption. Therefore, discovering the extent to which intake limiters influence 
variation is important. The standard deviation of daily supplement OM consumption 
indicates the cumulative stability of supplement intake. Cumulative stability of 
supplemental OMI was not affected by treatment (P = 0.35) nor monensin (P = 0.17) 
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when supplements contained the initial rate of limiter. A trend for a limiter × monensin 
interaction on DDG OMI (P = 0.13) was observed where intake variability of CONT 
was reduced (P = 0.03) from 1.34 kg/d to 0.78 kg/d when monensin was included. In 
addition, a trend towards increased cumulative stability was observed with heifers fed 
LIUR (P = 0.08) as variation decreased by 0.41kg/d with the inclusion of monensin 
(Figure 1).  
Comparisons of supplement OMI coefficient of variation (CV) are included 
because intake means varied among treatments. Calculated CV for DDG was affected by 
limiter (P < 0.01) during the initial treatment period; NACL was most variable (CV = 
47%) and differed from CONT (P < 0.01). The lowest CV value for supplement OMI 
was observed with heifers offered UREA (CV = 24%) followed by CONT (CV = 26%). 
Monensin inclusion did not affect CV of supplement OMI (P = 0.40) though a tendency 
for limiter × monensin combination effect was detected (P = 0.09). When monensin was 
included in the supplement, OM intake CV was reduced among heifers consuming 
CONT (P = 0.06) and LIUR (P < 0.01) by 54% and by 57%, respectively. In addition, a 
numerical decrease in supplement OMI CV was observed when monensin was included 
in combination with sodium chloride. An apparent increase in supplement OMI CV was 
detected when monensin was included in MLAC and UREA.   
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Figure 1. Cumulative stability of supplement OMI by treatment during the initial rate 
period. An "**" denotes significance at P < 0.05. An "*" denotes significance at P < 
0.15. 
 
 
When intake variation associated with treatment acclimation was removed, 
differences in OMI variability among treatments were magnified (P < 0.01). Heifers 
provided NACL (P < 0.01) and CAPR (P < 0.01) had lower supplement OM intake 
variation measures than those offered CONT. No other treatments differed from CONT 
in cumulative intake stability. In summation, treatments (MLAC and NACL) that 
effectively reduce DDG intake at these inclusion rates would be expected to do so 
without increasing the intake variability relative to that observed in heifers offered 
CONT.  
During the last 7 d of the experimental period, monensin did not affect 
cumulative stability of supplemental OMI (P = 0.76) and no limiter × monensin 
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interaction was detected (P = 0.76). Absence of a monensin effect on variation is 
contradictory of some previous findings (Burrin et al., 1988; Stock et al., 1995; Paisley 
and Horn, 1996).  
As a result of cumulative stability differences in the latter half of the period, it 
appears that acclimation to supplement during the initial days may have masked some 
influence of treatment. Regardless of monensin inclusion, measures of cumulative 
stability of NACL and LIUR during the terminal portion of the period were similar to 
those of during the entire period when supplement contained the ionophore. This 
suggests that although no overall treatment effect exists, monensin may aid in reducing 
variation in supplement intake resulting from initial exposure to sodium chloride or a 
combination of limestone and urea.  
Temporal stability. A supplemental regimen to deliver nutrients or increase 
carrying capacity may be either short- or long-term. In either case, the ability of a self-
fed supplement to be consumed at a stable rate over length of time - withstanding 
possible acclimation and/or aversion - is a valuable attribute. Supplements consumed 
with greater consistency over time, i.e., exhibiting temporal stability, will require less 
frequent adjustment to formulation and/or allowance to match targeted intakes. Mean 
rates of change in daily supplement OMI (slope of regression of intake on days) were 
used as indexes of the temporal stability of supplement intakes. 
When limiters were included in supplements at the initial rates, temporal stability 
of supplement OMI was affected by limiter (P < 0.01) as well as monensin (P = 0.04). In 
addition, an interaction of limiter × monensin tended to influence temporal stability of 
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supplement OM consumption (P = 0.10). Supplement OMI tended to increase at a 
greater rate by heifers assigned NACL (P = 0.010) and LIME (P = 0.10) relative to 
CONT. In contrast, supplement OMI of MLAC tended to increase over time (P = 0.06), 
but at a more modest rate than intake of OM from CONT. Increasing intake of all 
treatments over time suggest that heifers became acclimated  to DDG and all limiting 
agents, although to different degrees. 
Inclusion of monensin improved temporal stability by reducing daily OMI 
change by 0.05 kg/d when included in the supplement. Interaction of limiter × monensin 
resulted in more modest increases in daily supplement OM intake by heifers offered 
CONT (P < 0.02) and NACL (P < 0.02) when monensin was included. Daily 
consumption was reduced by 0.16 kg OM/d in both treatments. In addition, temporal 
stability of supplement OMI tended to improve (P = 0.14) by 0.09 kg OM/d with the 
inclusion of monensin in heifers fed LIUR. Enhancements in temporal stability of 
supplement intake, generally and in combination with salt, are consistent with earlier 
reports of fewer required changes to limiter inclusion when formulated to include 
monensin (Muller, 1986).  
Subsequent to removing data preceding the point of intake stability, analysis 
indicated that neither limiter (P = 0.43) nor monensin (P = 0.69) affected temporal 
stability of supplement OM intake. In addition, removal of the initial 7 d in the period 
removed the tendencies for a limiter × monensin interaction (P = 0.93). 
Over time, cattle may develop an aversion and reduce daily consumption 
possibly due to post-ingestive feedback (Provenza, 1995), become acclimated to the 
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limiter and consume more supplement, or sustain a constant level of intake. Within this 
set of observations, heifers consuming CONT, UREA, LIME, MLAC, and LIUR all 
consumed more supplement during the latter portion of the initial rate period relative to 
the overall mean. However, none of the limiter containing treatments differed from 
CONT in their degree of daily supplemental OMI change. During the truncated portion 
of the initial rate period, OMI of CONT increased by 0.23 kg/d. Therefore, from a 
temporal stability standpoint, a limiter would be effective if its absolute value rate of 
change was 0.23 kg/d or less. No treatments resulted in daily intake changes different 
from CONT and only LIME (0.28 kg) and LIUR (0.26 kg) had daily changes in 
supplement OM intake numerically greater than CONT.  
Mean daily supplement OMI change by heifers not fed monensin during the 
entire period was +0.18 kg/d. After days were removed to allow for acclimation, mean 
DDG consumption by heifers offered monensin increased by 0.21 kg/d. This data 
suggests that improved temporal stability by CONT and NACL treatment groups during 
the entire period was likely a result of a palatability response to monensin and that an 
acclimation occurred. From this, it appears that including monensin at the rate included 
here and in combination with the other agents at their respective levels will not influence 
temporal stability of supplement intake.  
Hay intake. Encompassing the entire 14-d initial treatment period, hay OMI was 
affected by limiter (P < 0.01) with UREA being the only treatment group to consume a 
similar amount to CONT (P = 0.84). Heifers fed NACL, MLAC, and LIME (P = 0.04) 
consumed more hay OM (P < 0.01) than those offered CONT, whereas heifers 
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consuming CAPR (P = 0.07) and LIUR (P = 0.08) tended to consume more. Monensin 
did not influence OMI of hay (P = 0.16), though consumption was numerically 
decreased by 0.17 kg/d. No limiter × monensin interaction was detected for hay OMI (P 
= 0.49). MacDonald and Klopfenstein (2004) estimated that hay DMI would decrease 
0.78 kg per kg of supplement consumed up to 1.91 kg/d supplement. Morris et al. (2005) 
estimated forage intake by beef heifers would decrease at a more modest rate of 0.24 or 
0.15 kg/d with high quality and low quality forages, respectively, when supplements 
were offered at rates more comparable to those observed in our study (2.72 kg/d). When 
supplement intakes from the initial treatment period were included in the linear 
prediction model of Morris et al. (2005), actual hay consumption was 52% of the amount 
predicted with all treatment groups having an actual to estimated ratio less than 1. 
Heifers consuming CONT consumed the most supplement and least amount of hay 
(34%) relative to the predicted hay DMI of 3.57. Heifers assigned NACL had the highest 
actual hay consumption relative to predicted amount (60%).  
Hay OMI during the last 7 days of the initial period was significantly affected by 
limiter (P < 0.01). Heifers fed LIUR, NACL and MLAC consumed more hay than those 
offered CONT (P < 0.05). Heifers consuming LIME (P = 0.09) and CAPR (P = 0.15) 
tended to have increased hay intake. It would appear that decreases in hay intake relative 
to control were result of forage substitution.  
Adding monensin to the supplements resulted in a decrease in daily hay OMI by 
15.81% (P < 0.05). These reductions are similar to those observed in cows on winter 
range (19.6% decrease; Lemenager et al., 1978). A tendency for a limiter × monensin 
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interaction was present for daily hay OMI (P = 0.11). Inclusion of monensin in the 
MLAC treatment reduced daily hay intake by 1.11 kg/d (P < 0.01), and tended to reduce 
hay OMI when heifers were fed UREA (P = 0.12), but had minimal influence on hay 
OMI for other treatments. Figure 2 contains measures of limiter × monensin effect on 
hay OMI. 
 
 
 
 
Figure 2. Hay OMI by treatment during the final 7 d of the initial rate period. An “*” 
denotes significance at P < 0.01. 
 
 
 Predicted hay intake based on the model of Morris et al. (2005) for the last 7 d of 
the initial supplementation period was slightly less than for the entire period due to 
increased supplement intake. Observed hay intake during the final 7 days were only a 
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were similar though hay intake by heifers consuming CONT was 34%lower than 
predicted values, whereas hay intake by heifers consuming CAPR and LIME were 46% 
and 45% of predicted values, respectively. By contrast, DDG intake was lowest by 
heifers offered MLAC and NACL. Forage intake was similar among these treatment 
groups with actual:estimated ratios of 0.54:1 and 0.55:1. Figure 3 shows supplement and 
hay DMI during the last 7 d of the period. The consistency by which hay was consumed 
in much lower amounts by all treatment groups suggests that the reduction is not related 
at these rates to specific treatment feedback but, instead, likely due in some part to the 
fact that supplement was consumed at a much higher rate in this study than in others 
(Morris et al., 2005). Additionally, use of linear prediction models for hay intake that 
were developed with lower levels of supplement intake than observed in this study may 
not be appropriate for estimating forage intake in this experiment.  
 Due to the objective of this study, no treatment group was assigned forage alone; 
thus, a precise measure of forage replacement by DDG is not available. Lower levels of 
actual hay consumed relative to modeled predictions may be due to higher supplement 
intakes. Supplement consumption during the final portion of the initial rate period was 
1.97% BW. This level approaches a two-fold increase in the highest DDG level (kg/d) 
for forage-fed cattle reported in the literature (Klopefenstein et al., 2007). Mean total 
DMI (hay + supplement) across all treatments during the final 7 d of this period was 
3.14% BW. Heifers fed LIME consumed the most total dietary DM per unit of BW 
(3.38%) whereas those provided MLAC, NACL, and UREA consumed the least (3.02).  
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Figure 3. Supplement DMI by treatment during the final 7 d of the initial rate period. 
Predicted hay estimates as a result of supplement intake are derived from: y = -0.5312x 
+ 12.864 (Morris et al., 2005). 
  
 
Treatment Period 2: 2X initial rate 
 Supplement intake. When limiting agents were included at double the initial rate, 
supplement OM intake was affected by limiter (P < 0.01, Table 6.) Daily supplement 
OM consumption of NACL and MLAC was lower than CONT (P < 0.01) whereas OMI 
of LIUR tended (P = 0.08) to be consumed at a reduced rate. No effects on supplement 
OMI by inclusion of monensin (P = 0.47) or the interaction of limiter × monensin (P = 
0.62) were detected.  
As with data in the initial treatment period, the first seven days of the second 
treatment period were removed and data from the final 7 d of the observation period 
were analyzed in order to reduce intake variability related to supplement acclimation. 
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During the final 7 d of the observation period, supplement OM intake was effected by 
limiter (P < 0.01) as intakes of NACL and MLAC were both reduced (P < 0.01) relative 
to CONT with respective means only 45% and 60% of CONT. Heifers fed LIUR 
consumed supplement OM at levels that tended to be lower (P = 0.12) than CONT. 
Neither monensin (P = 0.49) nor a combination of limiter × monensin (P = 0.27) 
produced an effect on DDG intake. Similar supplement OM intakes of LIME (P < 0.60) 
and UREA (P < 0.81) relative to CONT suggest that the tendency observed with LIUR 
resulted from either a combination effect of the agents or was due to their cumulative 
proportion in the supplement.    
Consumption of supplement limited by salt at this level is approximate to the 
2.97 kg DM/d reported by Schauer et al. (2004) when formulated inclusion was 16%. 
Inclusion of malic acid as a percentage of total OMI during this period was 2.63% 
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Table 6. Period 2 intake of hay and supplement, and supplement intake variance measures of a self-fed dried distillers’ grain supplement fed 
to growing beef heifers 
 Treatment1     
 CONT CAPR LIME LIUR MLAC NACL UREA SE L2 M3 L × M4 
---------------------------------------------------------------------DMI kg/d---------------------------------------------------------------------- 
14 d            
   Hay Intake 1.82 2.42a 1.66 2.18 3.49a 3.90a 1.71 0.22 0.01 0.01 0.01 
   Supplement Intake 4.92 4.60 5.20 4.27 2.64a 2.20a 4.99 0.37 0.01 0.58 0.49 
   Cumulative stability
 
0.96 0.75 0.86 0.69
 
0.88 0.83 0.90 0.11 0.63 0.62 0.18 
   Temporal stability 0.01 0.07 -0.02 0.05 0.07
 
0.05
 
0.04 0.03 0.28 0.48 0.24 
last 7 d            
   Hay Intake 2.06 2.49 1.97 2.57 4.09
a
 4.50
a
 1.73 0.29 0.01 0.03 0.02 
   Supplement Intake
 
4.96 4.82 5.03 4.42 2.88
a 
2.39
a 
5.04 0.36 0.01 0.59 0.20 
   Cumulative stability 0.81 0.67 0.93 0.53 0.71 0.97 1.01 0.15 0.20 0.36 0.86 
   Temporal stability -0.06 0.12a 0.12a 0.09b 0.16a 0.16a 0.15a 0.06 0.13 0.05 0.03 
----------------------------------------------------------------------OMI kg/d--------------------------------------------------------------------- 
14 d            
   Hay Intake 1.66 2.20a 1.52 1.99 3.17a 3.54a 1.56 0.19 0.01 0.01 0.01 
   Supplement Intake 4.69 4.21 4.64 3.89b 2.59a 2.00a 4.79 0.33 0.01 0.47 0.62 
   Cumulative stability 0.88 0.69 0.78 0.62a 0.82 0.58 0.83 0.10 0.22 0.51 0.15 
   Temporal stability 0.01 0.06 -0.02 0.04 0.07 0.04 0.04 0.03 0.30 0.47 0.23 
last 7 d            
   Hay Intake 1.88 2.26 1.79 2.34 3.71
a
 4.08
a
 1.58 0.26 0.01 0.03 0.02 
   Supplement Intake 4.72 4.41 4.49 4.02b 2.81a 2.14a 4.83 0.33 0.01 0.49 0.27 
   Cumulative stability 0.75 0.61 0.84 0.48 0.66 0.68 0.92 0.13 0.22 0.39 0.86 
   Temporal stability
 
-0.05 0.11
a 
0.11
a 
0.08
b 
0.15
a 
0.11
a 
0.14
a 
0.05 0.13 0.05 0.02 
1Treatments were: control (CONT; no limiter); salt (NACL, 20%); urea (UREA, 4%); limestone (LIME, 3.36%); malic acid (MLAC; 6%), calcium 
propionate (CAPR, 6%), and limestone plus urea (LIUR, 3.36 + 4%) 
2Limiter effect 
3Monensin effect 
4Limiter × monensin 
aWithin a row, means with a superscript differ from CONT at P < 0.05 
bWithin a row, means with a superscript differ from CONT at P < 0.15 
46 
 
whereas sodium chloride comprised 6.88% of intake. This level of malic acid as a 
percentage of total diet is similar to that of Foley et al. (2009) who reported a reduction 
in total intake of 4%. Greater reductions of total feed intake in this study may be the 
result of separate hay feeding. Hay intakes provided later depict compensation of 
supplement consumption by increased forage intake. In comparison of supplement OM 
intake reduction per unit of limiter inclusion, MLAC limited intake 5 percentage units 
with each increment included whereas sodium chloride reduced intake roughly 2.7 
percent for every unit formulated. Therefore, malic acid reduced supplement OMI 
roughly 1.85 times more effectively than sodium chloride at these levels.   
Cumulative stability. Variation in supplement OMI over the course of the second 
treatment period was not affected by limiter (P = 0.22) nor monensin inclusion (P = 
0.51). A limiter × monensin interaction tended to influence cumulative stability of 
supplement OMI (P = 0.15) as variation associated with MLAC increased by 0.34 kg/d 
with the addition of monensin (P = 0.07; Figure 4). Numerical differences in cumulative 
stability among treatments indicated that none of the limiting agents applied at their 
respective rate will improve or disrupt the cumulative stability of DDG fed alone. No 
monensin effect (P = 0.85) or limiter × monensin interaction (P = 0.68) was detected. 
Variation as a proportion of supplement OMI (CV) was different among limiters 
(P < 0.01) where heifers fed NACL (28%) and MLAC (32%) produced a greater degree 
of intake variation relative to CONT (19%, P = 0.01). No other treatments were 
significantly or numerically more variable than cattle offered unadulterated DDG.  
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Figure 4. Cumulative stability of OMI by treatment during the intermediate rate period. 
An “*” denotes significance at P = 0.07. 
 
 
Cumulative stability measures of supplement OM intake during the last 7 days of 
the treatment period were not different among limiters (P = 0.22) and no monensin effect 
was detected (P = 0.39). Additionally, no limiter × monensin interaction was detected (P 
= 0.86). Mean cumulative stability measures of supplement OMI across treatments 
decreased from the last 7 days of the initial treatment period (0.87 kg) to the last 7 days 
of the second treatment period (0.71 kg). Only NACL resulted in a noticeably decreased 
cumulative stability of supplement OMI (0.55 kg to 0.68 kg). All other treatments either 
approached replication or reduced intake volatility which may suggest that heifers were 
still adjusting to the supplement. This reasoning is not refuted by the fact measures of 
temporal stability in the second half of the initial treatment period indicated that 
supplement OMI was increasing for all treatments. 
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Coefficient of variation for supplement OMI over the final 7 d of the period was 
affected by limiter (P = 0.01) and tended to be influenced by monensin (P = 0.13). 
Supplement OM intake CV of NACL (31%, P < 0.01) and MLAC (27%, P < 0.04) were 
greater than CONT (16%). Supplement intake variation expressed as CV of supplement 
OMI was reduced numerically from 22% to 18% when monensin was included. 
Combination of limiter x monensin had no affect (P = 0.39) on CV of supplement OMI. 
Mean CV of supplement OMI among all treatments during the last 7 d of the second 
period was 2.14 percentage points lower than the last 7 d of the initial rate period 
indicating that cumulative stability was improving a faster rate than supplement intakes 
declined. This value was depressed by NACL which was the only treatment not to 
decrease CV of supplement OMI. Coefficient of variation of NACL OM intake 
increased from 22% in the initial period to 31% in the intermediate rate period.  
Temporal stability. Inclusion of limiting agents at twice the initial rate produced 
no differences in temporal stability of supplement OMI due to limiter (P = 0.30) or 
monensin (P = 0.47) In addition, no effect of a limiter × monensin combination was 
detected (P = 0.23).  
Using abridged data from the second treatment period, temporal stability of 
supplement OMI tended to differ by limiter (P = 0.13) with all treatments excluding 
CONT being consumed at a higher rate each day. All treatments differences from CONT 
(P < 0.05) were significant with the exception of LIUR, which tended to increase (P = 
0.07) consumption but at a lower rate. Inclusion of monensin in the supplement tended 
to reduce (P = 0.06) temporal variation of supplement OMI from +0.13 kg/d to +0.05 
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kg/d.  A limiter × monensin interaction on supplement OMI was detected (P = 0.02) 
resulting in reduced consumption consistency of CONT (P = 0.02) from +0.06 kg OM/d 
to -0.18 kg OM/d with the addition of monensin whereas temporal variation in heifers 
offered UREA improved (P < 0.01) from +0.29 kg OM/d to 0.00 kg OM/d. Heifers 
offered LIUR tended to consume supplement OM with more temporal variation when 
the supplement contained monensin (P = 0.06). Figure 5 contains measures of 
interaction influence on OMI temporal stability.  
Results of CONT and NACL responses when combined with monensin are in 
agreement with those of Muller et al. (1986) though previous literature appears to be 
vacant of effects on temporal stability due to limestone, urea, or a combination with 
monensin. Interactions of limiter × monensin in this period suggest that limiting agents 
may not have been incorporated at high enough rates in the initial treatment period 
where no response was not detected. That is to say that since rate of monensin inclusion 
was not different between periods, increasing proportion of limiter was responsible for 
provoking the combination effect. However, one could oppose certainty of this notion by 
referencing the conflicting results on monensin effect which produced no difference in 
temporal stability of supplement intake during the same time frame in the initial period 
but tended to reduced temporal variation here when formulated inclusion was 
unchanged. These results are difficult to explain and, although results of monensin 
inclusion in this period were deemed significant via statistical analysis, the nature of 
inconsistent results among treatment periods generates doubt in application to improve 
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temporal intake stability alone or in unison with any limiting agent other than sodium 
chloride. 
 
 
 
 
Figure 5. Temporal stability of supplement OMI by treatment during the final 7 d of the 
intermediate rate period. An "**" denotes significance at P < 0.05. An "*" denotes 
significance at P < 0.15. 
 
 
 
Hay intake. Analysis of hay OM intakes over the course of the entire second 
period produced a significant a response to limiter (P < 0.01), monensin (P < 0.01), and 
limiter × monensin interaction (P < 0.01).  Relative to CONT, NACL (P < 0.01), MLAC 
(P < 0.01), and CAPR (P < 0.03) consumed more hay OM daily. No other treatments 
differed. Inclusion of monensin decreased daily hay OMI by 0.40 kg. Heifers consuming 
MLAC consumed less hay OM (P < 0.01) when the supplement contained monensin and 
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were the only treatment group exhibiting a significant response to a limiter × monensin 
interaction though NACL tended (P = 0.07) to have the same effect.  
Among treatment groups, mean hay DMI for the overall period was closer to 
predicted levels of 66% using the linear model of Morris et al. (2005). Consumption of 
supplement limited by sodium chloride was lowest among treatments and resulted in 
most accurate hay DMI relative to prediction (86%), whereas heifers fed LIME 
consumed the most supplement and consumed only 54% of expected forage 
Analysis of data after removing the initial 7 d of the second treatment period 
continued to detect effects by limiter (P < 0.01) and monensin (P = 0.03) on hay OMI. In 
addition, an interaction of limiter × monensin also persisted (P < 0.02). Heifers assigned 
supplements containing NACL and MLAC both consumed more hay OM (P < 0.01) 
relative to CONT. Including monensin in the supplement decreased hay OMI by 0.45 
kg/d. As a product of limiter × monensin interaction, hay OM intakes by heifers 
consuming MLAC (P < 0.01) and NACL (P = 0.04) were reduced by respective 
measures of 2.15 kg/d and 1.18 kg/d when monensin was included. Figure 7 depicts 
OMI values relative to the interaction over the final 7 d of the period.  
As with observations from the initial treatment period, supplement intakes were 
generally higher in the last 7 d relative to the entire period. However, hay intakes during 
the current period increased along with supplement consumption which is trend reversal 
from the initial rate period. This suggests that although supplement intake increased, 
limiters may have limited intake to an extent and that heifers relied on forage to reach 
satiety. Forage intakes during the final 7 d of the second treatment period were 75% of 
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predicted by the Morris et al. (2005) model. Hay DMI by heifers consuming NACL was 
higher than predicted (1.06:1) with all others being lower than projected (Figure 8). If 
the assumption is made that lower hay intake during the initial rate period was attributed 
to the level of supplement consumption, then results here - where mean supplement 
intake was higher and actual hay consumption approached predicted levels - may 
indicate that an increase in heifer growth and gut capacity over the 14 day span was 
enough to accommodate intakes. 
 
 
 
 
Figure 6. Hay OMI by treatment during the final 7 d of the intermediate rate period. An 
“**” denotes significance at P < 0.01. An “*” denotes significance at P = 0.04. 
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Figure 7. DMI by treatment during the final 7 d of the intermediate rate period. 
Predicted hay estimates as a result of supplement intake are derived from: y = -0.5312x 
+ 12.864 (Morris et al., 2005) 
 
 
 
Treatment Period 3: 4X initial rate 
Supplement Intake. When treatments contained the highest level of limiter (4 x 
initial rate), supplement OMI over the entire period differed among treatment (P < 0.01) 
but was not affected by monensin (P = 0.41). Supplement OM intakes of NACL (P < 
0.01), MLAC (P < 0.01), and LIUR (P = 0.02) were lower relative to CONT. A limiter × 
monensin interaction (P = 0.10) tended to reduce OM consumption of MLAC by 1.80 
kg/d (P < 0.01) when monensin was included. Table 7 provides intakes and intake 
variation measures for the final treatment period.  
 Over the final 7 d of treatment period 3, intake of supplement OM continued to 
be affected by limiter (P < 0.01) and consumption of NACL, MLAC, and LIUR 
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Table 7. Period 3 intake of hay and supplement, and supplement intake variance measures of a self-fed dried distillers’ grain supplement fed 
to growing beef heifers 
 Treatment
1 
    
 CONT CAPR LIME LIUR MLAC NACL UREA SE L
2 
M
3 
L × M
4 
---------------------------------------------------------------------DMI---------------------------------------------------------------------- 
14 d            
   Hay Intake 2.12 2.82
a
 2.20 2.88
a
 3.44
a
 3.97
a
 1.67 0.20 0.01 0.01 0.01 
   Supplement Intake 4.74 5.72
b 
4.98 4.01 2.69
a 
0.96
a 
5.02 0.40 0.01 0.21 0.38 
   Cumulative stability
 
0.64 1.98
a 
0.59 0.65 0.73 0.34
b 
0.71 0.12 0.01 0.26 0.19 
   Temporal stability
 
0.01 -0.37
a 
-0.01 -0.07
b 
-0.09
a 
-0.03 -0.02 0.03 0.01 0.25 0.36 
last 7 d            
   Hay Intake 2.09 2.73
a
 2.48 2.91
a
 3.61
a
 3.93
a
 1.73 0.31 0.01 0.27 0.06 
   Supplement Intake
 
4.87 4.57 5.00 3.74
b 
2.33
a 
0.86
a 
5.03 0.44 0.01 0.17 0.39 
   Cumulative stability 0.51 0.57 0.49 0.48 0.48 0.27 0.69 0.11 0.27 0.98 0.10 
   Temporal stability
 
-0.07 -0.02 -0.01 -0.02 -0.14 -0.01 -0.15 0.07 0.51 0.72 0.51 
----------------------------------------------------------------------OMI--------------------------------------------------------------------- 
14 d            
   Hay Intake 1.93 2.56a 2.01 2.61a 3.13a 3.62a 1.52 0.17 0.01 0.01 0.01 
   Supplement Intake 4.52 5.04 4.45 3.41a 2.63a 0.77a 4.75 0.35 0.01 0.41 0.10 
   Cumulative stability
 
0.59 1.73
a 
0.51 0.57 0.68 0.16
a 
0.66 0.10 0.01 0.28 0.17 
   Temporal stability 0.01 -0.33 -0.01 -0.07 -0.09 -0.01 -0.02 0.03 0.01 0.25 0.36 
last 7 d            
   Hay Intake 1.90 2.48a 2.26 2.65a 3.28a 3.59a 1.58 0.28 0.01 0.26 0.06 
   Supplement Intake 4.64 4.03 4.47 3.16a 2.30a 0.73a 4.76 0.40 0.01 0.32 0.14 
   Cumulative stability
 
0.47 0.50 0.42 0.42 0.45 0.13
a
 0.64 0.10 0.04 0.96 0.09 
   Temporal stability -0.07 -0.02 -0.01 -0.02 -0.13 -0.01 -0.14 0.06 0.48 0.66 0.54 
1
Treatments were: control (CONT; no limiter); salt (NACL, 40%); urea (UREA, 8%); limestone (LIME, 6.72%); malic acid (MLAC; 12%), calcium 
propionate (CAPR, 12%), and limestone plus urea (LIUR, 6.72 + 8%) 
2Limiter effect 
3
Monensin effect 
4Limiter × monensin 
aWithin a row, means with a superscript differ from CONT at P < 0.05 
bWithin a row, means with a superscript differ from CONT at P < 0.15 
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continued to be consumed at a lower rate (P < 0.01) than CONT. No significant response 
to monensin was detected on supplement OMI (P = 0.32). A tendency for a limiter × 
monensin effect on supplement OMI (P = 0.14, Figure 9) persisted as consumption of 
MLAC decreased (P = 0.02) by 1.84 kg OM/d and LIUR (P = 0.14) tended to increase 
by 1.11 kg OM/d when monensin was incorporated in the supplement.  
Further intake reductions of supplement limited by sodium chloride, malic acid, and a 
combination of limestone and urea enhance confidence in their efficacy to restrict intake 
of DDG. A lack of response to monensin on supplement intake during this treatment 
period and throughout is surprising considering previous findings (Muller et al., 1986). 
Results of a limiter × monensin interaction in this set of observations are not supported 
by data in the previous treatment periods and are either by chance or a response to 
respective limiting agents at specific inclusion rates. 
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Figure 8. Supplement OMI by treatment during the final 7 d of the final rate period. An 
“**” denotes significance at P = 0.02. An “*” denotes significance at P = 0.14. 
 
 
 
Cumulative stability. Supplement OMI variability differed among treatments (P 
< 0.01) over the duration of the final period. Cumulative stability of CAPR was reduced 
(P < 0.01) relative to CONT whereas variation associated with NACL organic matter 
intake decreased (P < 0.01). Monensin (P = 0.28) did not affect variation of supplement 
OMI and no limiter × monensin interaction was detected (P = 0.17). Variation of OMI 
expressed as CV was affected by limiter (P < 0.01). Supplements containing CAPR 
(36%), MLAC (30%), and NACL (33%) had CVs higher (P < 0.01) than CONT (14%). 
No monensin (P = 0.82) effect or limiter × monensin interaction was detected (P = 0.74).  
Analysis of data after removal of supplement adaptation days continued to show 
a treatment effect (P = 0.05) on cumulative stability of supplement OMI as variation of 
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NACL intake was reduced (P = 0.02). No other treatments differed from the level of 
variation of CONT. Inclusion of monensin had no effect on cumulative stability of 
supplement OMI (P = 0.96) though a tendency for a limiter × monensin interaction (P = 
0.09) resulted in a decreased variation of 0.47 kg OM/d (P = 0.02) by heifers offered 
UREA. In addition, adding monensin to CAPR tended to increase (P = 0.15) daily 
supplement OMI variation (Figure 10). Coefficient of variation of supplement OMI was 
different (P < 0.01) among limiters as both MLAC (26%) and NACL (30%) were higher 
than CONT (10%, P < 0.01). Monensin had minimal influence on the CV of supplement 
intake (P = 0.16) though a limiter × monensin combination effect (P < 0.01) increased 
supplement OMI variation of NACL from 11% to 49% when monensin was added (P < 
0.01). A tendency for a reversed response due to monensin was observed with heifers 
offered UREA (P = 0.14) and LIUR (P = 0.07) as respective CV values were reduced by 
10% and 13% when supplement included monensin.  
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Figure 9. Cumulative stability of supplement OMI by treatment during the final 7 d of 
the final treatment period. An “*” denotes significance at P = 0.02.  
 
 
Temporal stability. Daily change in rate of supplement OM intake change over 
the entire 14 d of treatment period 3 differed by limiter (P < 0.01) as MLAC (P = 0.02) 
and CAPR (P < 0.01) consumption decreased daily relative to CONT which was the 
only treatment to be consumed at an increasing rate. Daily supplement OMI of LIUR 
tended to decrease (P = 0.06). No monensin affect (P = 0.25) or limiter × monensin 
interaction (P = 0.36) were detected.  
During the last 7 d of the period, temporal stability of daily supplement OM 
intake was not affected by limiter (P = 0.48) or monensin (P = 0.66). Additionally, no 
limiter × monensin interaction was present (P = 0.54). Temporal stability measures, both 
over the duration of treatment period 3 and during the last 7 d alone, indicate that 
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supplement consumption ceased to increase. Heifers offered CONT had daily 
supplement intake changes greater zero (0.01 kg) during the entire period but consumed 
less supplement (-0.01 kg/d) when the last 7 days were analyzed. Therefore, a couple of 
conclusions can be drawn. First, heifers no longer had intakes that were influenced by 
acclimation of DDG. In fact, consumption of CONT during the last 7 d of treatment 
period 3 was 0.09 kg less than consumption of CONT during the last 7 d of the previous 
period. Also, declining intakes would suggest that the window of limiter of inclusion 
rates of all respective limiters used here would likely accommodate accurate intake level 
prediction by regression procedures. 
 Hay intake. During the final treatment period, OM hay consumption was affected 
by limiter (P < 0.01) and monensin (P < 0.01). Forage consumption by heifers fed 
NACL , MLAC , CAPR , and LIUR increased (P < 0.01) relative to CONT whereas  
heifers assigned UREA tended to have decreased hay OM intake (P = 0.09) relative to  
CONT. When monensin was added to DDG, hay OMI decreased 0.35 kg/d. These 
reductions are similar to the decreases in forage intake during treatment period 2. Mean 
supplement intake during the second treatment period was 4.12 kg and mean intakes 
during this period are 4.01 kg. Therefore, monensin consumption would be essentially 
equal and confirms similarities in response across rates. A limiter × monensin interaction 
on hay OMI (P < 0.01) was also present in the final period where inclusion of monensin 
in MLAC resulted in a reduction of 1.71 kg. Including monensin in LIUR tended also to 
reduce hay OMI by 0.61 kg/d (P < 0.06). Across treatments, intakes were 74% of 
predictions using linear regressions (Morris et al., 1995). Heifers offered supplement 
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limited by salt consumed the least amount of DDG and consumed the most hay, though 
intake was still 1.63 kg less than predicted. Heifers receiving CAPR consumed the most 
supplement and were the only treatment group to match actual (2.82 kg) and predicted 
(2.80 kg) hay intakes. 
Hay OM intakes during the last 7 d of the final period continued to be affected by 
treatment (P < 0.01) but not monensin (P = 0.26). Consumption of CONT was lower (P 
< 0.01) than both NACL and MLAC. Heifers assigned LIME had higher OM hay intakes 
(P = 0.04) whereas CAPR (P = 0.07) and LIUR (P = 0.07) tended to consume more hay 
relative to CONT. A slight combination effect of limiter × monensin was observed on 
hay OMI (P = 0.06) as heifers offered MLAC consumed less hay (P < 0.01) when 
supplement contained monensin. Intake reductions due to MLAC × monensin were 1.94 
kg OM/d (Figure 11). 
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Figure 10.  Temporal stability of hay OMI by treatment during the final 7 d of the final 
treatment period. An “*” denotes significance at P = 0.01. 
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Table 8. Regression coefficients1 of OMI values over entire 14 d periods. 
Limiter2 β0  β1  β2 
CAPR 3.023* ± 0.3711  0.8621* ± 0.3892  -0.0842 ± 0.1033 
CAPR + M 2.246* ± 0.4791  1.171* ± 0.5025  -0.124 ± 0.1333 
CONT 2.794* ± 0.3711  1.435* ± 0.3892  -0.258* ± 0.1033 
CONT + M 3.207* ± 0.4791  1.24* ± 0.5025  -0.2216 ± 0.1333 
LIME 2.331* ± 0.4149  1.833* ± 0.4352  -0.3082* ± 0.1154 
LIME + M 1.965* ± 0.4149  2.026* ± 0.4352  -0.3685* ± 0.1154 
LIUR 2.383* ± 0.4149  1.29* ± 0.4352  -0.2759* ± 0.1154 
LIUR + M 2.629* ± 0.4149  0.999* ± 0.4352  -0.1832 ± 0.1154 
MLAC 3.443* ± 0.4149  -0.6529 ± 0.4352  0.052 ± 0.1154 
MLAC + M 2.904* ± 0.4149  0.3256 ± 0.4352  -0.0435 ± 0.1154 
NACL 3.154* ± 0.4149  -0.5937 ± 0.4352  0.0299 ± 0.1154 
NACL + M 3.12* ± 0.4149  -0.9662* ± 0.4352  0.2035 ± 0.1154 
UREA 2.244* ± 0.4149  1.886* ± 0.4352  -0.3343* ± 0.1154 
UREA + M 3.325* ± 0.4149  1.038* ± 0.4352  -0.1498 ± 0.1154 
*Coefficients differ from zero, P < 0.05 
1β0 = intercept, β1 = rate, β2 = rate*rate 
2Treatments were: control (CONT; no limiter); salt (NACL); urea (UREA); calcium carbonate (LIME); malic acid 
(MLAC), calcium propionate (CAPR), and limestone plus urea (LIUR), plus monensin ( + M) 
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supplement OMI of NACL (β1, P = 0.01; β2, P = 0.03) and MLAC (β1, P = 0.02; β2, P = 
0.06) could be predicted by rate of inclusion. No other treatment had rate of rate2 
coefficients that differed from zero. Table 8 contains regression parameters of OM 
supplement intake over the full 14 day periods.  
When initial days in each period were removed to suppress variation at least 
partially due to novelty, intercepts of supplement OMI were significant for all treatments 
(P < 0.01) excluding CONT+M (P = 0.03). Table 9 contains results of regression 
analysis of supplement intake during terminal portions of each period. Among all 
treatments, only supplement intake of NACL and MLAC could be projected by rate of 
inclusion. With each bifold increase in rate of limiter, supplement was reduced by 
NACL (P = 0.01) and MLAC (P = 0.02). When squared rate of limiter was incorporated 
into the model, NACL (P = 0.03) and MLAC (P = 0.06) were again the only treatments 
exhibiting a significant response. In each case, response to squared inclusion rate 
tempered the decrease in OMI associated with inclusion rate increases. Collectively, 
these figures demonstrate that the most drastic response to NACL and MLAC in a DDG 
supplement would be at the initial inclusion with intake reduction becoming less severe 
as supplement contained larger proportions of limiter. This is intuitive assuming that a 
limiter will negatively influence intake to a point that consumption levels approach zero 
and reductions associated with subsequent increases in limiter are increasingly minute.  
Intake by index. Due to the confounded structure of the trial, supplement intake, 
cumulative stability, and temporal stability measures were divided by the mean CONT 
response of each respective variable to provide a refined indication of treatment affect 
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Table 9. Regression coefficients1 of OMI values over last 7 d of periods. 
Limiter2 β0  β1  β2 
CAPR 4.157* ± 0.868  -0.3241 ± 0.8629  0.0258 ± 0.1523 
CAPR + M 3.088* ± 1.121  0.6294 ± 1.068  -0.1216 ± 0.1966 
CONT 5.69* ± 0.868  -0.2589 ± 0.8269  0.0296 ± 0.1523 
CONT + M 2.406* ± 1.121  1.859 ± 1.068  -0.2657 ± 0.1966 
LIME 4.989* ± 1.121  -0.125 ± 1.068  -0.0052 ± 0.1966 
LIME + M 4.454* ± 0.9705  -0.5665 ± 0.9245  0.0804 ± 0.1703 
LIUR 4.277* ± 0.9705  -0.3755 ± 0.9245  -0.0017 ± 0.1703 
LIUR + M 4.627* ± 0.9705  0.1643 ± 0.9245  -0.0568 ± 0.1703 
MLAC 5.421* ± 1.121  -2.571* ± 1.068  0.3803 ± 0.1966 
MLAC + M 4.216* ± 0.9705  -0.2303 ± 0.9245  -0.0148 ± 0.1703 
NACL 6.201* ± 0.9705  -2.426* ± 0.9245  0.3836* ± 0.1703 
NACL + M 5.385* ± 1.121  -0.8165 ± 1.068  0.0006 ± 0.1966 
UREA 3.856* ± 0.9705  0.8103 ± 0.9245  -0.2206 ± 0.1703 
UREA + M 3.232* ± 0.9705  0.8274 ± 0.9245  -0.1699 ± 0.1703 
*Coefficients differ from zero, P < 0.05 
1β0 = intercept, β1 = rate, β2 = rate*rate 
2Treatments were: control (CONT; no limiter); salt (NACL); urea (UREA); calcium carbonate (LIME); malic acid 
(MLAC), calcium propionate (CAPR), and calcium carbonate plus urea (LIUR), plus monensin ( + M) 
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within each period. As with the non-indexed data, within period observations were 
regressed on rate and rate2 to evaluate inclusion rate as a predictor of response variables.  
As expected, OM intake intercepts resulting from regressed 14-d indexed values 
were differed from zero for all treatments (P < 0.01). Among all treatments, reliable 
OMI prediction equations based on rate of limiter were produced for only LIUR+M (β1, 
P = 0.04; β2, P = 0.08), MLAC (β1 and β2, P < 0.01), NACL (β1, P < 0.01, β2, P = 0.02), 
and NACL+M (β1, P < 0.01; β2, P = 0.08). Table 10 contains results of indexed 
supplement OMI regressions over entire observation periods.  
Indexed OMI regressions inclusive of only the terminal seven days in each 
period again resulted in an intercept of 1.00 for CONT. Results of regressing the 
abridged data indicated that only supplement intake of UREA (DM; β1, P = 0.03; β2, P = 
0.04) could be predicted by rate of limiter inclusion (Table 11). 
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Table 10. Regression coefficients1 of indexed OMI values over entire 14 d periods. 
Limiter β0  β1  β2 
CAPR 0.9271* ± 0.0776  -01074 ± 0.0932  0.0342 ± 0.0211 
CAPR + M 0.996* ± 0.1687  -0.0347 ± 0.2142  0.0245 ± 0.0497 
CONT 1.000* ± 0.0938  0.000 ± 0.1192  0.000 ± 0.0278 
CONT + M 1.157* ± 0.0822  -0.0894 ± 0.1044  0.0156 ± 0.0242 
LIME 0.8794* ± 0.0823  0.116 ± 0.0988  -0.017 ± 0.0223 
LIME + M 0.8186* ± 0.101  0.134 ± 0.1212  -0.0255 ± 0.0274 
LIUR 0.8685* ± 0.1201  0.0078 ± 0.1525  -0.0119 ± 0.0354 
LIUR + M 1.138* ± 0.0801  -0.2527* ± 0.0962  0.0448 ± 0.0217 
MLAC 1.183* ± 0.1037  -0.503* ± 0.1316  0.0864* ± 0.0305 
MLAC + M 1.038* ± 0.1505  -0.2451 ± 0.1911  0.0462 ± 0.0446 
NACL 1.12* ± 0.0569  -0.4909* ± 0.0762  0.0709* ± 0.0177 
NACL + M 1.099* ± 0.1052  -0.4718* ± 0.1343  0.0541 ± 0.0318 
UREA 0.8212* ± 0.0864  0.1596 ± 0.1096  -0.0284 ± 0.0254 
UREA + M 1.231* ± 0.1312  -0.0398 ± 0.1666  0.0032 ± 0.0386 
*Coefficients differ from zero, P < 0.05 
1β0 = intercept, β1 = rate, β2 = rate*rate 
2Treatments were: control (CONT; no limiter); salt (NACL); urea (UREA); limestone (LIME); malic acid (MLAC), 
calcium propionate (CAPR), and limestone plus urea (LIUR), plus monensin ( + M) 
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Table 11. Regression coefficients1 of indexed OMI values over entire last 7 d of periods. 
Limiter β0  β1  β2 
CAPR 0.7656* ± 0.3216  0.1214 ± 0.3111  -0.0299 ± 0.0599 
CAPR + M 0.9311 ± 0.5635  0.0718 ± 0.545  -0.0104 ± 0.1049 
CONT 1.000* ± 0.2272  0.000 ± 0.2198  0.000 ± 0.0423 
CONT + M 0.6004* ± 0.2032  0.3258 ± 0.1966  -0.0508 ± 0.0378 
LIME 0.9818* ± 0.238  -0.008 ± 0.2302  0.0087 ± 0.0443 
LIME + M 0.762* ± 0.2589  0.1429 ± 0.2504  -0.0254 ± 0.0482 
LIUR 0.6102 ± 0.3668  0.2967 ± 0.3548  -0.0756 ± 0.0683 
LIUR + M 0.7803* ± 0.2128  0.0485 ± 0.2058  -0.0085 ± 0.0396 
MLAC 1.125* ± 0.4257  -0.5028 ± 0.4118  0.0869 ± 0.0792 
MLAC + M 0.6606 ± 0.7183  0.1182 ± 0.6702  -0.0255 ± 0.1272 
NACL 1.08* ± 0.2246  -0.434 ± 0.2248  0.058 ± 0.0436 
NACL + M 0.6612 ± 0.3342  -0.0273 ± 0.324  -0.031 ± 0.0629 
UREA 0.3269 ± 0.2251  0.5777* ± 0.2178  -0.1008* ± 0.0491 
UREA + M 0.8377* ± 0.3465  0.248 ± 0.3352  -0.0475 ± 0.0645 
*Coefficients differ from zero, P < 0.05 
1β0 = intercept, β1 = rate, β2 = rate*rate 
2Treatments were: control (CONT; no limiter); salt (NACL); urea (UREA); calcium carbonate (LIME); malic acid 
(MLAC), calcium propionate (CAPR), and calcium carbonate plus urea (LIUR), plus monensin ( + M) 
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 Cumulative stability. Regressed measures of OM intake cumulative stability over 
14 d durations indicated the presence of variation among all treatments. However, only 
NACL (β1, P = 0.30; β2, P = 0.03) and CAPR (β1, P = 0.13; β2, P < 0.01) yielded 
equations that contained a coefficient deviating from zero and thus could be predicted by 
rate (Table 12). 
Removing the initial 7 d of each period resulted in no treatment with statistically 
significant parameter estimates indicating that cumulative stability could not be 
estimated by rate of limiter (Table 13). 
Cumulative stability by index. When cumulative stability values of the full 
periods were indexed against the mean of the CONT and regressed on rate and rate 
squared,  β2 coefficients of CAPR (P < 0.01) and CAPR + M (P < 0.01) were 
substantially greater than CONT (Table 14).  
When the initial seven days of each period were removed, regressions identified 
LIUR as the sole treatment with predictable measures of supplement OMI cumulative 
stability as a function of limiter inclusion rate (Table 15). With each rate increase, 
supplement OM intake cumulative stability would be expected to decrease (P = 0.04) 
and do so at a decreasing rate (P = 0.05). 
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Table 12. Regression coefficients1 OMI cumulative stability values over entire 14 d periods. 
Limiter β0  β1  β2 
CAPR 1.17* ± 0.2623  -0.3729 ± 0.2426  0.1379* ± 0.047 
CAPR + M 0.7427* ± 0.3386  -0.1105 ± 0.3131  0.0752 ± 0.0607 
CONT 0.9471* ± 0.2623  0.0889 ± 0.2426  -0.0444 ± 0.047 
CONT + M 1.142* ± 0.3386  -0.1447 ± 0.3131  0.0013 ± 0.0607 
LIME 1.38* ± 0.2932  -0.3363 ± 0.2712  0.0216 ± 0.0525 
LIME + M 0.9695* ± 0.2932  0.1525 ± 0.2712  -0.061 ± 0.0525 
LIUR 1.04* ± 0.2932  -0.0638 ± 0.2712  -0.0089 ± 0.0525 
LIUR + M 1.13* ± 0.2932  -0.234 ± 0.2712  0.0152 ± 0.0525 
MLAC 1.038* ± 0.2932  -0.2606 ± 0.2712  0.0347 ± 0.0525 
MLAC + M 1.034* ± 0.2932  0.0457 ± 0.2712  -0.026 ± 0.0525 
NACL 0.8723* ± 0.2932  0.2846 ± 0.2712  -0.1154* ± 0.0525 
NACL + M 0.7862* ± 0.2932  0.0657 ± 0.2712  -0.0563 ± 0.0525 
UREA 0.6614* ± 0.2932  0.2192 ± 0.2712  -0.0453 ± 0.0525 
UREA + M 0.8765* ± 0.2932  0.0199 ± 0.2712  -0.029 ± 0.0525 
*Coefficients differ from zero, P < 0.05 
1β0 = intercept, β1 = rate, β2 = rate*rate 
2Treatments were: control (CONT; no limiter); salt (NACL); urea (UREA); calcium carbonate (LIME); malic acid 
(MLAC), calcium propionate (CAPR), and limestone plus urea (LIUR), plus monensin ( + M) 
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Table 13. Regression coefficients1 OMI cumulative stability values over last 7 d of periods. 
Limiter β0  β1  β2 
CAPR 0.677 ± 0.4859  0.0549 ± 0.4703  -0.0362 ± 0.0866 
CAPR + M 0.9748 ± 0.6273  -0.3159 ± 0.6071  0.068 ± 0.118 
CONT 1.277* ± 0.4859  -0.4212 ± 0.4703  0.052 ± 0.0866 
CONT + M 1.761* ± 0.6273  -0.8707 ± 0.6071  0.1336 ± 0.1118 
LIME 1.556* ± 0.6273  -0.4974 ± 0.6071  0.0507 ± 0.1118 
LIME + M 0.994 ± 0.5432  0.0794 ± 0.5258  -0.0522 ± 0.0969 
LIUR 1.598* ± 0.5432  -0.6 ± 0.5258  0.0712 ± 0.0969 
LIUR + M 1.635* ± 0.5432  -0.6028 ± 0.5258  0.0751 ± 0.0969 
MLAC 0.6348 ± 0.6273  -0.0279 ± 0.6071  -0.0129 ± 0.1118 
MLAC + M 1.068 ± 0.5432  -0.1286 ± 0.5258  -0.0066 ± 0.0969 
NACL 0.3781 ± 0.5432  0.408 ± 0.5258  -0.1038 ± 0.0969 
NACL + M 0.3072 ± 0.6273  0.6073 ± 0.6071  -0.1526 ± 0.1118 
UREA 0.8769 ± 0.5432  0.1253 ± 0.5258  -0.0409 ± 0.0969 
UREA + M 1.253* ± 0.5432  -0.505 ± 0.5258  0.0808 ± 0.0969 
*Coefficients differ from zero, P < 0.05 
1β0 = intercept, β1 = rate, β2 = rate*rate 
2Treatments were: control (CONT; no limiter); salt (NACL); urea (UREA); calcium carbonate (LIME); malic acid 
(MLAC), calcium propionate (CAPR), and calcium carbonate plus urea (LIUR), plus monensin ( + M) 
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Table 14. Regression coefficients1 of indexed OMI cumulative stability over 14 d periods. 
Limiter β0  β1  β2 
CAPR 0.9282* ± 0.2706  -0.43 ± 0.325  0.2523* ± 0.0734 
CAPR + M 1.061* ± 0.209  -0.4681 ± 0.2653  0.202* ± 0.0615 
CONT 1.000* ± 0.2153  0.000 ± 0.2735  0.000 ± 0.0637 
CONT + M 1.254* ± 0.2982  -0.195 ± 0.3786  0.0299 ± 0.0878 
LIME 0.9874* ± 0.098  -0.0244 ± 0.1176  -0.0155 ± 0.0266 
LIME + M 0.8114* ± 0.2335  0.2546 ± 0.2804  -0.051 ± 0.0634 
LIUR 1.09* ± 0.2562  -0.2425 ± 0.3252  0.0609 ± 0.0754 
LIUR + M 0.9062* ± 0.1381  -0.055 ± 0.1658  0.0026 ± 0.0375 
MLAC 1.214* ± 0.1925  -0.4454 ± 0.2443  0.0925 ± 0.0567 
MLAC + M 1.116* ± 0.2226  -0.0145 ± 0.2828  0.0161 ± 0.066 
NACL 0.924* ± 0.2548  0.0857 ± 0.3415  -0.0597 ± 0.0792 
NACL + M 0.8181* ± 0.219  0.0179 ± 0.2794  -0.0431 ± 0.0662 
UREA 0.6895* ± 0.2228  0.1998 ± 0.2828  -0.01 ± 0.0656 
UREA + M 0.7294* ± 0.1744  0.1533 ± 0.2214  -0.0344 ± 0.0513 
*Coefficients differ from zero, P < 0.05 
1β0 = intercept, β1 = rate, β2 = rate*rate 
2Treatments were: control (CONT; no limiter); salt (NACL); urea (UREA); calcium carbonate (LIME); malic acid 
(MLAC), calcium propionate (CAPR), and calcium carbonate plus urea (LIUR), plus monensin ( + M) 
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Table 15. Regression coefficients1 of indexed OMI cumulative stability over last 7 d of periods. 
Limiter β0  β1  β2 
CAPR 0.3119 ± 0.5701  0.3569 ± 0.5515  -0.0658 ± 0.1061 
CAPR + M 0.4074 ± 0.6298  0.2374 ± 0.6092  -0.0185 ± 0.1172 
CONT 1.000 ± 0.564  0.000 ± 0.5456  0.000 ± 0.105 
CONT + M 1.193 ± 0.7864  -0.2119 ± 0.7607  0.025 ± 0.1464 
LIME 1.244* ± 0.53  -0.1268 ± 0.5127  -0.007 ± 0.0987 
LIME + M 1.066 ± 0.8254  0.102 ± 0.7984  -0.0325 ± 0.1536 
LIUR 2.486* ± 0.6745  -1.556* ± 0.6524  0.29 ± 0.1256 
LIUR + M 1.447* ± 0.448  -0.5811 ± 0.4333  0.0961 ± 0.0834 
MLAC 0.7983 ± 0.5334  0.0722 ± 0.5159  -0.0317 ± 0.0993 
MLAC + M 1.675* ± 0.6239  -0.7681 ± 0.5822  0.1539 ± 0.1105 
NACL -0.1232 ± 0.6442  0.9924 ± 0.6449  -0.226 ± 0.1249 
NACL + M 0.2238 ± 0.5362  0.521 ± 0.5199  -0.1291 ± 0.1008 
UREA 0.3482 ± 1.34  0.6815 ± 1.296  -0.0901 ± 0.2495 
UREA + M 0.4824 ± 0.7974  0.5418 ± 0.7713  -0.113 ± 0.1484 
*Coefficients differ from zero, P < 0.05 
1β0 = intercept, β1 = rate, β2 = rate*rate 
2Treatments were: control (CONT; no limiter); salt (NACL); urea (UREA); calcium carbonate (LIME); malic acid 
(MLAC), calcium propionate (CAPR), and calcium carbonate plus urea (LIUR), plus monensin ( + M) 
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Temporal stability. Inclusive of entire 14 d periods, regressions of supplement 
OMI temporal stability across rates resulted in no differences at the intercepts (Table 
16). Rate of limiter inclusion coefficients appeared indicate effects of CONT (β1, P = 
0.05; β2, P = 0.03), UREA (β1, P = 0.05; β2, P = 0.04), MLAC + M (β1, P = 0.06; β2, P = 
0.03), and LIUR (β1, P = 0.10; β2, P = 0.03).  
A repeat of the analysis using only the terminal 7 d of each treatment period 
removed the influence on each of the treatments. Intercepts of all treatments excluding 
LIUR + M (P < 0.01) were essentially zero. In addition, LIUR + M was the only 
treatment to have an influence of rate (β1, P = 0.04; β2, P = 0.11) on OMI temporal 
stability (Table 17).  
Temporal stability by index. Change in OM supplement intake over time across 
full periods regressed on rate and rate2 resulted in no intercepts that differed from zero. 
Among all treatments, rate of limiter inclusion of CAPR could reliably predict temporal 
stability (P = 0.01) and was the sole treatment to indicate a significant response. When 
rate2 was applied as a variable, CAPR (P < 0.01), CAPR+M (P = 0.01), and UREA+M 
(P = 0.03) indicated a predictable effect on temporal stability change. Table 18 contains 
results of entire period regressions.  
When the abridged version of the data was analyzed to evaluate trends across 
rates, CONT+M was the sole treatment producing a significant intercept (P = 0.03), 
response to rate (P = 0.02), and effect of rate2 (P = 0.03) on supplement OMI temporal 
stability relative to CONT. Values of intercepts and coefficients are contained in Table 
19. 
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Table 16. Regression coefficients1 of OMI temporal stability values over 14 d periods. 
Limiter β0  β1  β2 
CAPR 0.1229 ± 0.1740  0.1012 ± 0.1665  -0.0557 ± 0.0313 
CAPR + M -0.0322 ± 0.2246  0.2174 ± 0.215  -0.0714 ± 0.0404 
CONT -0.2881* ± 0.174  0.3435* ± 0.1665  -0.0689* ± 0.0313 
CONT + M 0.266 ± 0.2246  -0.2315 ± 0.215  0.0431 ± 0.0404 
LIME 0.2131 ± 0.1945  -0.1015 ± 0.1862  0.0121 ± 0.035 
LIME + M 0.147 ± 0.1945  -0.0392 ± 0.1862  -0.002 ± 0.035 
LIUR -0.1523 ± 0.1945  0.3095 ± 0.1862  -0.0773 ± 0.035 
LIUR + M 0.085 ± 0.1945  0.0119 ± 0.1862  -0.0086 ± 0.035 
MLAC -0.1333 ± 0.1945  0.1712 ± 0.1862  -0.0409 ± 0.035 
MLAC + M -0.2714* ± 0.1945  0.3652* ± 0.1862  -0.0795* ± 0.035 
NACL -0.0931 ± 0.1945  0.2272 ± 0.1862  -0.0535 ± 0.035 
NACL + M -0.1718 ± 0.1945  0.2589 ± 0.1862  -0.0554 ± 0.035 
UREA -0.2842* ± 0.1945  0.3733* ± 0.1862  -0.076* ± 0.035 
UREA + M 0.0359 ± 0.1945  0.0172 ± 0.1862  -0.0096 ± 0.035 
*Coefficients differ from zero, P < 0.05 
1β0 = intercept, β1 = rate, β2 = rate*rate 
2Treatments were: control (CONT; no limiter); salt (NACL); urea (UREA); calcium carbonate (LIME); malic acid 
(MLAC), calcium propionate (CAPR), and calcium carbonate plus urea (LIUR), plus monensin ( + M) 
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Table 17. Regression coefficients1 of OMI temporal stability values over last 7 d of periods. 
Limiter β0  β1  β2 
CAPR 0.0101 ± 0.2614  0.1575 ± 0.251  -0.0376 ± 0.048 
CAPR + M 0.2338 ± 0.3375  -0.0341 ± 0.324  -0.0107 ± 0.062 
CONT 0.4847 ± 0.2614  -0.2894 ± 0.251  0.0373 ± 0.048 
CONT + M 0.6071 ± 0.3375  -0.5783 ± 0.324  0.1027 ± 0.062 
LIME -0.0301 ± 0.3375  0.0858 ± 0.324  -0.0205 ± 0.062 
LIME + M 0.5613 ± 0.2923  -0.2512 ± 0.2806  0.0228 ± 0.0537 
LIUR 0.3708 ± 0.2923  -0.1985 ± 0.2806  0.0299 ± 0.0537 
LIUR + M 0.8848* ± 0.2923  -0.5984* ± 0.2806  0.0877 ± 0.0537 
MLAC 0.1531 ± 0.3375  0.0475 ± 0.324  -0.026 ± 0.062 
MLAC + M 0.3547 ± 0.2923  -0.0187 ± 0.2806  -0.0265 ± 0.0537 
NACL 0.0999 ± 0.2923  0.0613 ± 0.2806  -0.0191 ± 0.0537 
NACL + M 0.1985 ± 0.3375  -0.1156 ± 0.324  0.0167 ± 0.062 
UREA 0.1596 ± 0.2923  0.0928 ± 0.2806  -0.0436 ± 0.0537 
UREA + M 0.3964 ± 0.2923  -0.2484 ± 0.2806  0.0362 ± 0.0537 
*Coefficients differ from zero, P < 0.05 
1β0 = intercept, β1 = rate, β2 = rate*rate 
2Treatments were: control (CONT; no limiter); salt (NACL); urea (UREA); calcium carbonate (LIME); malic acid 
(MLAC), calcium propionate (CAPR), and calcium carbonate plus urea (LIUR), plus monensin ( + M) 
76 
 
Table 18. Regression coefficients1 of indexed OMI temporal stability over 14 d periods. 
Limiter β0  β1  β2 
CAPR -50.86 ± 88.77  312.8* ± 106.6  -161.6* ± 24.09 
CAPR + M -25.79 ± 112.8  207.9 ± 143.2  -110.2* ± 33.21 
CONT 1.000 ± 43.09  0.000 ± 54.73  0.000 ± 12.75 
CONT + M 1.976 ± 65.26  -19.87 ± 82.84  10.73 ± 19.21 
LIME 1.699 ± 53.01  -9.025 ± 63.67  4.705 ± 14.39 
LIME + M -3.08 ± 58.29  20.95 ± 70.01  -11.05 ± 15.82 
LIUR -12.27 ± 90.15  101.2 ± 114.4  -53.57 ± 26.53 
LIUR + M 0.2108 ± 48.92  -0.0056 ± 58.75  0.3123 ± 13.27 
MLAC -7.723 ± 53.1  63.05 ± 67.41  -33.37 ± 15.63 
MLAC + M -5.999 ± 120.3  63.01 ± 152.8  -32.35 ± 35.65 
NACL -1.481 ± 31.16  16.38 ± 41.75  -8.799 ± 9.684 
NACL + M -0.1647 ± 7.875  5.659 ± 10.05  -2.76 ± 2.379 
UREA 0.6306 ± 21.82  -0.0033 ± 27.69  0.612 ± 6.421 
UREA + M -4.188 ± 23.73  33.69 ± 30.12  -18.3* ± 6.985 
*Coefficients differ from zero, P < 0.05 
1β0 = intercept, β1 = rate, β2 = rate*rate 
2Treatments were: control (CONT; no limiter); salt (NACL); urea (UREA); calcium carbonate (LIME); malic acid 
(MLAC), calcium propionate (CAPR), and calcium carbonate plus urea (LIUR), plus monensin ( + M) 
77 
 
Table 19. Regression coefficients1 of indexed OMI temporal stability over last 7 d of periods. 
Limiter β0  β1  β2 
CAPR -2.289 ± 4.405  3.685 ± 4.261  -0.906 ± 0.82 
CAPR + M -2.125 ± 5.418  3.107 ± 5.241  -0.542 ± 1.009 
CONT 1.000 ± 4.085  0.000 ± 3.952  0.000 ± 0.761 
CONT + M 9.117* ± 3.267  -10.09* ± 3.16  2.13* ± 0.6082 
LIME 1.059 ± 3.147  -0.1133 ± 3.045  0.0517 ± 0.5859 
LIME + M -0.9616 ± 4.293  3.147 ± 4.152  -0.7712 ± 0.7991 
LIUR 4.001 ± 4.258  -3.557 ± 4.118  0.7107 ± 0.7926 
LIUR + M -2.386 ± 3.118  4.362 ± 3.016  -0.9468 ± 0.5805 
MLAC -2.756 ± 2.083  4.069 ± 2.015  -0.7094 ± 0.3877 
MLAC + M 1.399 ± 6.549  -0.9934 ± 6.111  0.507 ± 1.159 
NACL -2.801 ± 2.354  4.553 ± 2.356  -0.943 ± 0.4565 
NACL + M 0.7029 ± 1.594  0.1736 ± 1.545  -0.0685 ± 0.2997 
UREA -4.217 ± 13.01  5.887 ± 12.59  -0.8559 ± 2.423 
UREA + M 3.124 ± 4.707  -3.307 ± 4.553  0.774 ± 0.8762 
*Coefficients differ from zero, P < 0.05 
1β0 = intercept, β1 = rate, β2 = rate*rate 
2Treatments were: control (CONT; no limiter); salt (NACL); urea (UREA); calcium carbonate (LIME); malic acid 
(MLAC), calcium propionate (CAPR), and calcium carbonate plus urea (LIUR), plus monensin ( + M) 
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 Hay intake. When mean OM intakes of all days within periods were regressed by 
treatment, intercepts of CAPR (P < 0.01), CONT+M (P = 0.03), MLAC+M (P = 0.05), 
and UREA+M (P < 0.01) were different from zero (Table 20). Additionally, coefficients 
associated with CAPR (β1, P < 0.01; β2, P = 0.02) indicated significance by treatment 
inclusion. Organic matter hay intake was also influenced by the inclusion of UREA+M 
(β1, P = 0.05; β2, P = 0.07). Influence of rate on NACL+M intake was detected (P = 
0.05) though intercept only tended to differentiate from zero (P = 0.09).   
 When indexed, forage OM intake intercepts of CAPR+M (P < 0.01), LIME (P = 
0.05), LIME+M (P = 0.04), LIUR (P < 0.01), and UREA (P = 0.05) differed from 
CONT. Organic matter coefficients are contained in Table 21. Only consumption of 
CAPR+M appeared to be influenced by limiter inclusion (β2, P = 0.01). 
Conclusion 
Intake of supplements containing MLAC and NACL were consistently lower 
than CONT over the course of the trial. Cumulative stability of intake was improved 
with each treatment when initial days were removed to allow for acclimation and 
decreased with most treatments as limiter inclusion was elevated. After removal of initial 
days, intake cumulative stability of all limiter-containing treatments were essentially 
equal to that of heifers offered CONT. Rates of intake change over time were less 
predictable by individual period. All treatments were consumed at an increasing rate 
relative to CONT during the intermediate period but did not differ during the final 
period. All limiting agents served to influence supplement intake and hay intake seemed 
to increase as limiters restricted supplement consumption.
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Table 20. Regression coefficients1 of sorghum x sudangrass OMI by treatment. 
Limiter β0  β1  β2 
CAPR 6.37* ± 0.101  7.05* ± 0.129  -1.05* ± 0.03 
CAPR + M 5.56 ± 1.54  6.87 ± 1.96  -0.941 ± 0.454 
CONT 6.67 ± 1.70  3.45 ± 2.16  -0.432 ± 0.501 
CONT + M 5.70* ± 0.30  2.90 ± 0.38  -0.317 ± 0.088 
LIME 6.83 ± 2.52  4.88 ± 3.20  -0.836 ± 0.741 
LIME + M 8.46 ± 2.83  3.83 ± 3.60  -0.647 ± 0.834 
LIUR 7.14 ± 1.75  4.53 ± 2.22  -0.214 ± 0.515 
LIUR + M 7.84 ± 0.88  4.05 ± 1.12  -0.463 ± 0.259 
MLAC 7.05 ± 2.40  14.43 ± 3.05  -2.29 ± 0.707 
MLAC + M 8.69* ± 0.711  5.31 ± 0.902  -0.871 ± 0.209 
NACL 6.87 ± 1.71  14.68 ± 2.17  -2.52 ± 0.503 
NACL + M 5.65 ± 0.761  13.63* ± 0.966  -2.37 ± 0.224 
UREA 7.34 ± 0.806  3.52 ± 1.02  -0.714 ± 0.237 
UREA + M 6.14* ± 0.214  3.54* ± 0.271  -0.569 ± 0.063 
*Coefficients differ from zero, P < 0.05 
1β0 = intercept, β1 = rate, β2 = rate*rate 
2Treatments were: control (CONT; no limiter); salt (NACL); urea (UREA); limestone (LIME); malic 
acid (MLAC), calcium propionate (CAPR), and limestone plus urea (LIUR), plus monensin ( + M) 
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Table 21. Regression coefficients1 of indexed sorghum x sudangrass OMI by treatment. 
Limiter β0  β1  β2 
CAPR 0.981 ± 0.16  0.338 ± 0.203  -0.064 ± 0.047 
CAPR + M 0.826* ± 0.004  0.397* ± 0.006  -0.068* ± 0.001 
CONT 1.00 ± 0.00  0.00 ± 0.00  0.00 ± 0.00 
CONT + M 0.888 ± 0.171  -0.034 ± 0.217  0.009 ± 0.05 
LIME 1.01* ± 0.075  0.134 ± 0.096  -0.037 ± 0.022 
LIME + M 1.26* ± 0.073  -0.054 ± 0.093  -0.003 ± 0.02 
LIUR 1.07* ± 0.022  0.106 ± 0.028  0.007 ± 0.006 
LIUR + M 1.20 ± 0.11  -0.018 ± 0.139  0.006 ± 0.032 
MLAC 1.13 ± 0.443  0.973 ± 0.562  -0.184 ± 0.13 
MLAC + M 1.36 ± 0.281  0.015 ± 0.357  -0.015 ± 0.083 
NACL 1.09 ± 0.367  1.01 ± 0.466  -0.203 ± 0.108 
NACL + M 0.88 ± 0.244  0.989 ± 0.309  -0.2 ± 0.071 
UREA 1.12* ± 0.094  -0.065 ± 0.119  -0.008 ± 0.028 
UREA + M 0.947 ± 0.129  0.004 ± 0.164  -0.008 ± 0.038 
*Coefficients differ from zero, P < 0.05 
1β0 = intercept, β1 = rate, β2 = rate*rate 
2Treatments were: control (CONT; no limiter); salt (NACL); urea (UREA); calcium carbonate (LIME); malic acid 
(MLAC), calcium propionate (CAPR), and calcium carbonate plus urea (LIUR), plus monensin ( + M) 
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Monensin inclusion did not affect supplement intake or cumulative stability of intake. 
Influence of monensin on temporal stability seemed to vary by days observed and rate of 
limiter. Rate of supplement intake change was only affected by monensin during the 
latter half of the intermediate rate period. Interactions of limiter × monensin were not 
detected on supplement intake or cumulative stability and influence on temporal stability 
paralleled monensin influence. Monensin did, however, consistently decrease hay intake 
of heifers assigned MLAC.  
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CHAPTER III 
 COMPARISON OF SODIUM CHLORIDE AND DL-MALIC ACID AS INTAKE 
LIMITING AGENTS IN A SELF-FED DRIED DISTILLERS’ GRAIN 
SUPPLEMENT 
 All animal care and use procedures described in this protocol were approved by 
the Texas A&M University Animal Care and Use Committee (AUP 2009-239). 
Research was conducted at the Texas AgriLife Research Center outside of McGregor, 
TX during late winter and spring of 2011. 
Materials and methods 
 Sixty angus-sired, weanling steers (257 kg mean initial BW) were used to 
compare the efficacy of a novel intake limiting agent relative to sodium chloride when 
included at identical rates in a self-fed, monensin-containing corn distillers’ grains 
(DDG) supplement. Steers were stratified by weight and randomly assigned (2 steers per 
pen) to pens equipped with four Calan gates (American Calan, Inc., Northwood, NH). 
Each steer was fitted with keys enabling access to two Calan gate feed bunks, one 
containing chopped hay and the other containing supplement. Initially, heifers were 
provided daily with 1 kg of DDG and ad libitum access to sorghum x sudangrass hay in 
the adjacent bunk until acclimated to the feeding system and bunk assignments. Steers 
were weighed on the first day that treatments were applied. 
Treatments were randomly assigned to pen and bunk. Limiting agents were 
included in treatments at 4 identical rates. Each treatment, excluding negative control, 
contained 66.1mg·kg-1·suppl.-1 of monensin. Treatments were: negative control, no 
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limiter (CON); monensin (RUM); sodium chloride (NACL) included at 8%, 16%, 24%, 
and 32% (8NACL, 16NACL, 24NACL, and 32NACL); and malic acid (MLAC, 
Baddley Chemicals, Inc., Baton Rouge, LA) included at 8%, 16%, 24%, and 32% 
(8MLAC, 16MLAC, 24MLAC, and 32MLAC). Treatments were prepared in bulk 
every week by combining components in a portable rotary mixer for a duration of at 
least five minutes and until visual appraisal of consistency was achieved. Treatments 
were sampled from mixer immediately after manufacturing of batch and composited 
within week.  
All animals had continuous, ad libitum access to chopped sorghum x sudangrass 
hay. Hay availability was monitored daily during supplement feeding and supplied on an 
individual basis when necessary. Supplement was initially fed at predetermined amounts 
that were dependent upon limiter and inclusion rate after review of previous trials. 
Modifications of daily supply to both conserve feed and ensure ad libitum access were 
made on an individual basis. Supplement refusals were weighed daily at 0700 and 
disappearance from previous day was added. Modifications to delivery amount were 
applied on an individual basis throughout the trial to ensure availability and minimize 
waste.  Every seventh day, accumulated refusals of both supplement and hay were 
sampled and discarded then replaced with fresh feed to mimic weekly replenishment of a 
bulk feeder in practice. Supplement refusal samples were composited by treatment each 
week whereas hay refusal sample were retained for individual steers. 
Samples of manufactured treatments, unfed hay, and refusals of both were placed in a 
forced-air oven at 60ºC for 96 h to determine DM content. Samples were ground to pass 
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through a 1 mm screen of a Wiley mill (Thomas Wiley, Laboratory Mill Model 4, 
Thomas Scientific Co., Philadelphia, PA) and analyzed for ash, NDF, ADF, and CP. 
Organic matter was calculated from ash content of a 0.5 g sample placed into a muffle 
furnace (500º C) for 8 hours. Fiber content was estimated using ANKOM 200 Fiber 
Analyzer (ANKOM Technologies, Inc., Macedon, NY). Crude protein values were 
derived using Dumas combustion (Rapid-N-Cube, Elementar America, Inc., Mt. Laurel, 
N.J.). Nutrient composition of treatments and hay are provided in Table 22. 
Within periods, response variables (mean supplement intake, mean hay intake, 
cumulative stability of supplement intake, and temporal stability of supplement intake) 
were analyzed as a completely randomized design with a 4 × 2 factorial treatment 
arrangement using the mixed model procedure of SAS 9.2. Limiter type, percentage of 
inclusion, and their interaction were included as effects in the model. Mean responses for 
each limiter were compared to the control treatment using t-tests. Pairwise comparisons 
among limiters were not performed. Significance of all statistical analysis was declared 
where P < 0.05. Reports of trends in data are limited to results where P < 0.15. 
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Table 22. Nutrient composition of treatments1 and sorghum x sudangrass hay by week.  
 Nutrient, % 
Item DM OM NDF ADF CP 
Week 1 
 
     
     8MLAC 88.93 93.34 29.48 7.94 
 
23.88 
 
    16MLAC 88.29 93.26 25.07 6.61 21.17 
 
     24MLAC 87.87 93.98 23.36 5.72 19.35 
     32MLAC 92.82 94.92 22.18 5.50 17.27 
     8NACL 
 
89.75 85.60 28.18 7.58 24.03 
     16NACL 90.82 75.96 26.04 6.87 21.27 
    24NACL 91.45 70.21 23.87 6.22 18.84 
     32NACL 87.06 57.30 19.77 5.11 17.68 
     CON 89.41 92.44 32.09 8.97 26.11 
     RUM 89.11 92.16 31.43 8.66 25.81 
     Hay 91.42 90.68 58.96 33.67 10.92 
      
Week 2      
     8MLAC 92.88 92.06 31.01 8.09 25.17 
     16MLAC 92.14 93.32 29.18 7.83 22.87 
     24MLAC 91.54 94.41 25.01 6.56 20.59 
     32MLAC 92.82 94.92 22.18 5.50 17.27 
     8NACL 
 
93.10 85.32 30.71 8.15 25.59 
     16NACL 93.00 86.44 31.49 8.45 25.03 
    24NACL 93.47 72.33 26.00 6.86 20.76 
     32NACL 94.82 60.19 21.36 5.71 17.47 
     CON 89.46 92.21 30.18 9.22 27.40 
     RUM 93.36 92.45 31.93 9.01 25.92 
     Hay 90.35 90.06 56.14 29.35 10.40 
      
Week 3      
     8MLAC 92.90 91.40 33.44 9.41 25.42 
     16MLAC 91.37 92.14 29.41 8.32 23.35 
     24MLAC 91.54 94.41 25.01 6.56 18.59 
     32MLAC 89.76 93.96 25.65 6.71 16.25 
     8NACL 
 
93.45 88.11 36.84 11.78 25.09 
     16NACL 93.25 80.69 34.00 11.29 25.03 
    24NACL 93.34 73.07 29.67 9.20 20.81 
     32NACL 94.16 62.52 26.05 8.18 18.56 
     CON 89.00 92.22 31.89 8.46 26.51 
     RUM 92.89 92.31 38.48 12.28 26.83 
     Hay 92.13 89.92 57.40 30.13 10.41 
continued on next page 
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Table 22. (continuted) 
 Nutrient, % 
Item DM OM NDF ADF CP 
Week 4      
     8MLAC 92.83 93.80 42.30 15.41 23.79 
     16MLAC 90.69 93.02 35.73 12.84 20.86 
     24MLAC 89.11 95.01 32.09 11.60 18.59 
     32MLAC 89.14 95.40 27.78 9.56 16.09 
     8NACL 
 
92.80 84.52 39.85 14.86 25.18 
     16NACL 92.89 79.12 36.86 13.64 22.50 
    24NACL 93.19 73.94 35.44 13.15 20.29 
     32NACL 94.66 60.19 30.63 11.41 17.49 
     CON 92.64 92.43 33.41 9.31 25.91 
     RUM 92.73 94.23 46.50 17.74 26.72 
     Hay 92.03 90.64 58.82 30.33 10.11 
      
Week 5      
     8MLAC 93.01 94.27 42.06 16.89 24.38 
     16MLAC 91.45 95.51 38.11 13.89 21.84 
     24MLAC 89.05 95.40 29.43 10.85 18.08 
     32MLAC 89.54 96.19 28.32 10.18 16.46 
     8NACL 
 
92.62 89.03 44.71 17.42 25.18 
     16NACL 92.46 78.53 38.60 15.03 22.60 
    24NACL 93.60 66.24 32.30 11.67 19.19 
     32NACL 93.95 57.60 28.35 10.43 16.70 
     CON 92.62 94.29 29.88 8.48 27.17 
     RUM 93.04 94.67 47.68 17.92 26.65 
     Hay 91.85 90.31 57.56 29.10 10.18 
      
Week 6      
     8MLAC 92.34 93.88 34.91 11.43 24.46 
     16MLAC 90.15 93.74 28.75 9.24 21.98 
     24MLAC 89.05 95.40 29.43 10.85 18.08 
     32MLAC 89.77 96.35 26.42 8.59 16.22 
     8NACL 
 
93.11 86.54 34.12 11.65 26.08 
     16NACL 93.13 79.49 34.42 11.71 23.43 
    24NACL 94.55 68.82 27.83 9.26 20.62 
     32NACL 93.39 60.74 24.30 14.11 18.13 
     CON 92.87 94.79 31.82 9.04 26.82 
     RUM 89.56 93.97 46.03 16.11 27.40 
     Hay 91.85 90.70 59.21 29.86 9.74 
1Control (CON), malic acid at 8% (8MLAC), 16% (16MLAC), 24% (24MLAC),  
  
32% (32MLAC), sodium chloride at 8% (8NACL), 16% (16NACL), 24% (24NACL), 
32% (32NACL), and monensin (RUM). All except CON contained 66.1 mg/kg monensin. 
mg/mg/kkmonensin. 
 mg/kg of monensin.  
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The effect of increasing percentage of limiters in supplement on response 
variables was evaluated using regression procedures of SAS v 9.2, where inclusion rate 
and inclusion rate squared were included as predictor variables in the model. 
Results and discussion 
 
 Based on the results of the initial screening trial, limiting agents malic acid 
(MLAC) and sodium chloride (NACL) were employed at identical rates to compare 
efficacy in limiting supplement intake. As in the initial trial, measures included intake 
level to identify agent ability to decrease consumption, cumulative stability as an 
indication of the regularity of nutrient delivery within a herd at a given inclusion rate, 
and temporal stability as a measure of effective duration (Table 23). 
Supplement intake  
Comparison of supplement intake by steers fed CON and RUM indicated that the 
supplement intake was not affected by monensin (DM, P = 0.66; OM, P = 0.62). As a 
result, combined means of CON and RUM are used to contrast the influence of MLAC 
and NACL. Intake of supplement limited by MLAC was consistently lower compared to 
supplement containing NACL at identical rates. Consumption of supplement containing 
8% limiter on an as-fed basis differed (DM and OM, P < 0.01) between limiter-
containing treatments and was reduced relative to unlimited feed (4.87 kg, DM). 
Relative to supplement containing no limiter, DMI was 66.5 percentage units lower 
when limited by MLAC (1.66 kg, DM). Similarly, intake was only 70.7% of unlimited 
supplement when NACL (3.45 kg, DM) was included. Response to malic acid at this rate 
was greater than predicted based on the findings in Trial 1 where a similar inclusion rate 
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of 6% resulted in a 42 percentage point reduction in DMI. However, response to NACL 
in this study was comparable to the reduction in Trial 1 a formulated inclusion of 10% 
inclusion in supplement resulted in DMI of 3.63 kg. In direct comparison of limiters in 
this trial alone, MLAC was 2.11 times more effective at limiting intake at this rate than 
was NACL on a DM basis. This response measure is almost identical to that observed in 
the initial period of the first trial (2.02). When supplement in this trial contained an 
incremental rate increase of limiter, consumption was 15.8% and 31.7% of unlimited 
supplement on a DM basis when agent was 16MLAC and 16NACL, respectively. 
Differences in intake between limiters (DM and OM, P < 0.01) at this rate were again 
twice as pronounced (2.01) on a DM basis when 16MLAC (0.77 kg) was used compared 
to 16NACL (1.55 kg).  
Supplement containing 24MLAC was consumed at a lower rate (P = 0.01) on a 
DM basis and tended to differ (P = 0.10) from 24NACL when expressed as OMI. 
Reduction in DMI measured 4.37 kg when 24MLAC (0.50 kg) was included whereas 
24NACL (1.16 kg) in supplement resulted in a decrease of 3.71 kg relative to 
unregulated DDG. Due to the inverse relationship of organic matter content and sodium 
chloride inclusion, it is likely that decreases in OMI resulted in intake values not 
statistically different among treatments though DMI continued to be more heavily 
altered by use of MLAC. In comparison of treatments formulated to include 24% limiter 
on an as-fed basis, MLAC reduced intake 2.34 times as much as NACL. Differences in 
supplement intake on a DM basis were 0.67 kg whereas supplement OMI measured only 
0.35 kg.
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Table 23. Intake, cumulative stability, and temporal stability of supplement intake by limiter and inclusion rate.  
 Intake  Cumulative stability  Temporal stability 
Rate1 MLAC NACL SE P  MLAC NACL SE P  MLAC NACL SE P 
8%               
   DM 1.64 3.45 0.233 0.01  1.45 1.91 0.171 0.01  -0.276 0.529 0.202 0.01 
   OM 1.55 3.09 0.19 0.01  1.37 1.65 0.145 0.06  -0.247 0.585 0.172 0.01 
16%               
   DM 0.77 1.55 0.242 0.01  0.62 0.94 0.178 0.08  -0.08 0.331 0.210 0.06 
   OM 0.70 1.41 0.197 0.01  0.60 0.73 0.150 0.42  -0.118 0.58 0.179 0.01 
24%               
   DM 0.50 1.16 0.253 0.01  0.36 0.65 0.186 0.12  0.246 0.34 0.22 0.67 
   OM 0.55 0.90 0.207 0.10  0.35 0.44 0.157 0.57  0.499 0.645 0.188 0.44 
32%               
   DM 0.18 0.86 0.253 0.01  0.11 0.49 0.186 0.05  0.107 0.212 0.22 0.64 
   OM 0.17 0.58 0.207 0.05  0.11 0.25 0.157 0.37  0.077 0.351 0.188 0.15 
1Inclusion rate on an as-fed basis.  
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Finally, supplement intake at 32% limiter inclusion differed (DM, P = 0.01; OM, P = 
0.05) between limiting agents used. Supplement intake was mediated to a greater degree 
by 32MLAC (0.18 kg, DM) relative to 32NACL (0.85 kg, DM). At this inclusion rate, 
MLAC reduced intake 4.65 times greater on a DM basis than did NACL. Due to the 
extent that consumption was reduced by MLAC, differences in OMI between the two 
treatments were significant despite the level of sodium chloride. 
Results indicating a two-fold intake reduction when supplement is limited by 
MLAC relative to NACL are supported by factorial analysis. Dry matter consumption of 
8MLAC was only numerically different (P = 0.71) than that of 16NACL though 
differences within treatments were significant (MLAC and NACL, P < 0.01) at these 
rates. Similarly, supplement DMI by steers offered DDG formulated to included 16% 
MLAC was not different (P = 0.73) than those fed supplement composed of 32% NACL. 
Level of DMI at inclusion rates of 16% and 32% differed within treatment (MLAC, P = 
0.02; NACL, P < 0.01). 
 In regards to overall intake, steers assigned CON and RUM consumed a mean 
9.05 kg (DM). Across the range of limiter inclusions, steers fed supplement containing 
MLAC had similar total DMI values ranging from 67.98% to 76.92% of unlimited 
supplement. By contrast, steers fed supplement limited by NACL expressed a total DMI 
range of 69.64% to 93.53% of supplement containing no limiter. These results suggest 
that an initial, lower inclusion of MLAC may lead to a relatively substantial decrease in 
total DMI with progressive increments having a diminished effect (appear quadratic). On 
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the other hand, total DMI reductions by steers consuming NACL appear to roughly align 
with inclusion rate (appear linear).  
 Reliability of inclusion rate as a predictor of supplement intake was derived by 
regressing mean intakes within treatment. Table 24 contains regression coefficients for 
all dependent variables. Intakes across all percentage rates resulted in intercepts that 
were different from zero (P < 0.01) on both a DM and OM basis for both treatments. In 
addition, significant differences from zero at both inclusion rate (DM and OM, P < 0.01) 
and inclusion rate squared (DM and OM, P < 0.01) indicate a predictable response of 
both MLAC and NACL on supplement intake. Each formulated inclusion percentage of 
MLAC and NACL in supplement decreased DMI by 0.37 and 0.26 kg, respectively. 
Response to inclusion was reduced to a degree of 0.007 when MLAC was included and 
by 0.004 kg when NACL was used. 
Cumulative stability 
No differences in cumulative stability were detected (DM, P = 0.26; OM, P = 
0.25) among steers consuming CON and RUM. Therefore, means used in comparison to 
MLAC and NACL treatments are inclusive of both. 
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Table 24. Regression coefficients1 for intake, intake variance, and time stability. 
Item2 β0  SE  β1  SE  β2  SE 
MLAC3            
   DMI 4.067* ± 0.2997  -0.3675* ± 0.0449  0.0074* ± 0.0013 
   OMI 4.337* ± 0.283  -0.3445* ± 0.0424  0.0069* ± 0.0013 
   DMCS 2.607* ± 0.1289  -0.1641* ± 0.0193  0.0027* ± 0.0006 
   OMCS 2.466* ± 0.1213  -0.1546* ± 0.0182  0.0026* ± 0.0005 
   DMTS 0.7439* ± 0.3035  -0.1013* ± 0.0455  0.0027* ± 0.0014 
   OMTS  0.6541* ± 0.2902  -0.0839 ± 0.0435  0.0023 ± 0.0013 
NACL4            
   DMI 4.980* ± 0.3073  -0.2632* ± 0.046  0.0042* ± 0.0014 
   OMI 4.666* ± 0.2665  -0.2544* ± 0.0399  0.004* ± 0.0021 
   DMCS 2.687* ± 0.1258  -0.1331* ± 0.0188  0.002* ± 0.0006 
   OMCS 2.526* ± 0.0991  -0.1405* ± 0.0148  0.0022* ± 0.0005 
   DMTS 0.9196* ± 0.2952  -0.0495 ± 0.0442  0.0009 ± 0.0013 
   OMTS 0.815* ± 0.2655  -0.0152 ± 0.0397  0.0001 ± 0.0012 
*P-values differ at 0.05 
1β0 = intercept, β1 = percent limiter, β2 = percent*percent 
2DMI = dry matter intake, OMI = organic matter intake, DMCS = dry matter cumulative stability, OMCS = organic 
matter cumulative stability, DMTS = dry matter temporal stability, OMTS = organic matter temporal stability 
3Malic acid (MLAC; 0%, 8%, 16%, 24%, 32%). All levels formulated to include 66.1 mg/kg monensin. 
4 Salt (NACL; 0%, 8%, 16%, 24%, 32%). All levels formulated to include 66.1 mg/kg monensin.  
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Cumulative stability of supplement intake was improved over unlimited 
supplement (2.63 kg, DM) by both limiters at all rates of inclusion. In comparison of 
limiting agents, inclusion at the lowest and highest rate resulted in significant intake 
stability improvements when MLAC was used relative to NACL. Intermediate rates of 
limiter in supplement here tended to induce the same result on a DM basis. Both 
improvement over unregulated supplement and consistency in limiter influence oppose 
the erratic findings in Trial 1. Comparison of mean intake variation between treatments 
formulated to contain 8% limiter differed (DM, P < 0.01; OM, P = 0.06) resulting in 
cumulative stability that was reduced by 0.46 kg/d (24%) when NACL was included as 
opposed to MLAC. At formulated inclusion of 16% (P = 0.08) and 24% (P = 0.12), 
MLAC was more effective at stabilizing DMI by measures of 0.32 kg and 0.29 kg, 
respectively. Cumulative stability of supplement intake by steers consuming 32MLAC 
and 32NACL differed (P = 0.05) on a DM basis but was similar (P = 0.37) on an OM 
basis. When limiting agent composed 32% of supplement, DMI variation within 
treatment was decreased 0.38 kg/d (78%) with use of MLAC relative to NACL.  
 Analysis of cumulative stability regression values indicate that percentage and 
squared percentage rate of limiter inclusion are of use in predicting cumulative stability 
of both MLAC and NACL in a DDG supplement. A similar decline in cumulative 
variance is predicted for both limiters (DM and OM, P < 0.01) when included at like 
rates. By percentage of inclusion, MLAC tempered cumulative variance of supplement 
DMI by 0.16 kg whereas NACL improved stability by 0.13 kg. Additionally, 
significance of the β2 coefficient (DM and OM, P < 0.01) with both limiters suggests 
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that response to inclusion percentage will dissipate at increased levels. Improvements in 
supplement DMI cumulative stability were dissipated by 0.002 kg with each incremental 
inclusion of both agents. A visual reference to cumulative stability by rate in this study is 
provided in Figure 11.  
 
Figure 11.  Regressed DMI cumulative stability by percentage of limiter inclusion. 
 
 
Temporal stability 
As with intake and cumulative stability, monensin had no affect on temporal 
stability. As a collective mean, daily intake change of both CON and RUM over the 
course of the trial was +0.95 kg/d.  
Daily changes in supplement consumption were significantly different between 
limiter-containing treatments when included at 8% (DM and OM, P < 0.01) and 16% 
(DM, P = 0.06; OM, P = 0.05). At 8% inclusion, DMI decreased 0.28 kg/d when limited 
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by MLAC and increased 0.53 kg/d when NACL was included. An intake reduction by 
steers consuming this level of MLAC contradicts the slight temporal increase (0.16 kg) 
observed in Trial 1 when supplement contained 6%. Heifers consuming DDG containing 
10% salt during Trial 1 increased their daily intake to a lesser degree (0.16 kg vs. 0.53 
kg) relative to steers in this trial consuming 8NACL. Organic matter intake of 
supplement formulated to include 8% limiter decreased 0.25 kg/d and increased 0.59 
kg/d when containing MLAC and NACL, respectively. When 16MLAC and 16NACL 
were provided, DM temporal stability measures were -0.08 kg and 0.33 kg, respectively. 
Organic matter of supplement including 16% limiter was consumed at a decreasing rate 
(-0.11 kg/d) when limiter was MLAC and at an increasing rate (0.58 kg/d) when 
tempered by NACL. Differences in temporal stability at inclusion levels of 24% (DM, P 
= 0.67; OM, P = 0.44) and 32% (DM, P = 0.64; OM, P = 0.15) were undetected.  
When daily mean temporal stability measures within treatment were regressed, 
analysis indicated that only temporal intake change of MLAC could be reliably predicted 
by inclusion rate. Intercept (0.74 kg, DM) of supplement temporal stability associated 
with MLAC (DM, P = 0.02; OM, P = 0.03) as well as coefficients of percentage (-0.37 
kg, DM, P = 0.03; OM, P = 0.06) and percentage squared (0.01 kg, DM, P = 0.05; OM, 
P = 0.09) suggest that increasing concentration will decrease temporal variance at a 
decreasing rate with progressive inclusions. On the other hand, regression of NACL 
temporal shifts resulted in an intercept that differed significantly from zero (0.92 kg, DM 
and OM, P = 0.01) but neither a response to percentage (-0.05, DM, P = 0.27; OM, P = 
0.71) nor percentage squared (0.00 kg, DM, P = 0.51; OM, P = 0.94) proved to be useful 
96 
 
in temporal predictability. Figure 14 contains a visual comparison of regressed temporal 
stability.     
 
Figure 12. Regressed DMI temporal stability by percentage of limiter inclusion. 
 
 
 Hay intake. Overall, hay intake was unaffected by monensin (DM, P = 0.56; OM, 
P = 0.53) or limiter type (DM, P = 0.30; OM, P = 0.29). Hay intakes by percentage of 
limiter inclusion are provided in Table 25.   
 
Table 25. Mean daily hay intakes (kg) by percentage of limiter inclusion.  
 MLAC  NACL 
Percentage DM OM  DM OM 
   0% 4.18 3.80  4.18 3.80 
   8% 5.33 
 
 
 
 
4.88  5.02 4.57 
   16% 5.40 5.04  5.71 5.25 
   24% 5.67 5.21  5.49 5.01 
   32% 5.97 5.47  5.45 4.99 
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 When regressed across percentage rates of limiter inclusion (Table 26), hay 
intake intercepts of both limiters differed from zero on both a DM and OM basis (P < 
0.01). Percentage of limiter in supplement affected hay intake of steers fed both MLAC 
(DM and OM, P < 0.01) and NACL (DM and OM, P < 0.01). With each percentage 
increase of limiting agent incorporated into DDG, hay intake increased by 0.12 kg when 
limited by MLAC and 0.13 kg when NACL was used. Squaring the percentage of limiter 
in supplement resulted in only a slight response with both agents. Response to MLAC in 
terms of hay DMI was relatively stable (-0.002 kg, P = 0.07) across the range of limiter 
inclusion though the effect on hay DMI by steers fed NACL was more pronounced (-
0.003 kg, P = 0.03).  
 
 
Figure 13. Regressed DMI of sorghum x sudangrass hay by percentage of limiter 
inclusion. 
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Table 26. Regression coefficients1 of indexed DM and OM intakes.  
Item2 β0  SE  β1  SE  β2  SE 
MLAC3            
   DMI 4.296* ± 0.2657  0.1207* ± 0.0398  -0.0022 ± 0.0012 
   OMI 3.9145* ± 0.2466  0.1134* ± 0.037  -0.0021 ± 0.0011 
NACL4            
   DMI 4.1812* ± 0.2730  0.1291* ± 0.0408  -0.0029* ± 0.0012 
   OMI 3.8038* ± 0.2567  0.1203* ± 0.0384  -0.0027* ± 0.0012 
*P-values < 0.05 
1β0 = intercept, β1 = percent limiter, β2 = percent*percent 
2DMI = dry matter intake, OMI = organic matter intake, DM SD = dry matter standard deviation, 
OM SD = organic matter standard deviation, DM Slope = daily change in DMI, OM Slope = daily 
change in OMI 
3Malic acid (MLAC; 0%, 8%, 16%, 24%, 32%). All levels included 66 mg/kg monensin. 
4 Salt (NACL; 0%, 8%, 16%, 24%, 32%). All levels included 66 mg/kg monensin.  
 
Conclusion 
Intake of MLAC was consistently lower than NACL at each level of inclusion. 
Cumulative stability of MLAC was improved relative to that of NACL at 8% inclusion 
but differences diminished as inclusion was increased. Daily intake reductions were 
more pronounced with MLAC up to 16% inclusion. Hay intake was reduced relative to 
RUM by limiter inclusion up to 8% MLAC and 16% NACL.  
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CHAPTER IV 
 EVALUATION OF STACKED PRODUCTION TECHNOLOGIES ON ADG  
OF CALVES GRAZING SMALL GRAIN WINTER PASTURES 
All animal care and use procedures described in this protocol were approved by 
the Texas A&M University Animal Care and Use Committee (AUP 229-239). Research 
was conducted from January through April 2011 at the Beef Research Unit at Texas 
A&M University, College Station, TX.  
Materials and methods 
One hundred crossbred steers (240 kg mean initial BW) were used in a split-plot 
design to evaluate the influence of beef production technologies on ADG over the course 
of a 98-d grazing period on yearling cattle grazing irrigated winter oats (Avena sativa L.) 
pastures. Steers were weighed and at weaning and received a multivalent killed viral 
vaccine (Vira Shield 6+VL5, Novartis Animal Health US, Inc., Greensboro, NC) and 
clostridial vaccinine (Clostri Shield 7, Novartis Animal Health US, Greensboro, NC). 
Body weights were obtained again 23 days prior to the study to obtain sorting weights. 
All steers originated from a single location (Texas AgriLife Research Center, McGregor, 
TX) and were relocated to study site and fed hay in a drylot until prior to trial initiation.  
Sub plot treatments were randomly assigned to experimental units (steers). 
Whole plot treatments were hand-fed energy supplement (Table 27) fed at a rate of 0.91 
kg·hd-1·d-1 with (RUM; 135 mg·hd-1·d-1) or without (CON) monensin (Rumensin 90; 
Elanco Division, Eli Lilly and Co., Indianapolis, IN). Sub plot treatments were arranged 
in a 2 x 2 factorial and consisted of administration of a metaphylactic (MM; Micotil 300, 
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Elanco Division, Eli Lilly and Co., Indianapolis, IN) dosed at 1.5 ml/cwt of initial BW 
or no metaphylaxis (PT) and a single dose implant (I; TEG with Tylan, Elanco Division, 
Eli Lilly and Co., Indianapolis, IN) given at initial day of study in the middle third of the 
right ear or no implant (0).  Four whole plot experimental units (paddocks) consisted of 
four replicates containing equal numbers (n=3) of each sub plot treatment experimental 
units whereas remaining paddocks contained on additional, randomly assigned  sub plot 
experimental unit. Thus, four paddocks contained 12 steers and four paddocks contained 
13 steers. Paddocks were approximately 6.22 ha equating to stocking rates of 1.93 hd per 
ha. Sort weights were used to allocate steers to whole plot replicates. Figure 48 depicts 
layout of paddocks and treatment assignments. 
 Shrunk body weights were collected in the morning of d 28, 56, 84, and 105. On 
the preceding days, steers were gathered in the afternoon and held overnight without 
access to feed or water. Manual palpation of ear was performed to confirm presence of 
implant. After weighing, steers were immediately resorted into returned to assigned 
paddocks.   
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Table 27. Composition of hand-fed energy supplement fed to steers grazing oat pastures (% as-
fed) 
  Treatment 
  monensin 
 
control 
Item  batch 11  batch 22 batch 11  batch 22 
Dried distillers’ grains   97.35%  94.51%  97.50%   94.70% 
Commercial mineral   2.50%    2.43%    2.50%     2.43% 
Molasses  -    2.91%  -     2.87% 
Rumensin 903,4     0.150%     0.146%  -  - 
1Batch 1 was fed d 1 through 34 
2Batch 2 was fed d 35 through 105 
3135 and 131 mg·hd-1·d-1 of active ingredient in Batch 1 and 2, respectively  
4Elanco Division, Eli Lilly and Co., Indianapolis, IN 
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  Supplement was provided daily in metal troughs (3.05 meters) placed in relative 
proximity to water. Every seventh day, remaining supplement was gathered prior to feed 
delivery and weighed in order to calculate supplement intake·hd-1·d-1. Due to low intakes 
of monensin-containing supplement, molasses (3%) was added to both diets and fed 
beginning d 35. In order tom minimize effects of supplement intake variation between 
dietary treatments, supplement allowance was reduced to 0.45 kg·hd-1·d-1 beginning on d 
42. A timeline is presented in figure #. Samples from each batch of formulated 
supplement were collected weekly. Samples were dried in a forced air oven (60º C) for 
96 h for DM determination. Samples were ground to pass through a 1 mm screen of a 
Wiley mill (Thomas Wiley, Laboratory Mill Model 4, Thomas Scientific Co., 
Philadelphia, PA) and analyzed for ash, NDF, ADF, and CP. Organic matter was 
calculated from ash content of a 0.5 g sample placed in an ashing oven (500º C) for 8 h.  
Fiber content was estimated using an ANKOM 200 Fiber Analyzer (ANKOM 
Technologies, Inc., Macedon, NY). Crude protein values were derived using Dumas 
combustion (Rapid-N-Cube, Elementar America, Inc., Mt. Laurel, N.J.). 
Procurement of forage samples to estimate availability and nutrient content 
coincided with weigh dates. Within each paddock, 8 samples of forage clipped to 
approximately 2.5 cm were obtained by tossing at random a 0.1 sq meter quadrant. Each 
sample was placed into a pre-weighed paper bag and dried in a forced air oven (60º C) 
for 96 h to determine mean DM content. Mean sample weights were multiplied by 
94512.38 to convert m2 to forage mass per ha. With each collection, samples were 
composited by paddock and ground to pass through a 1 mm screen of a Wiley mill 
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(Thomas Wiley, Laboratory Mill Model 4, Thomas Scientific Co., Philadelphia, PA) and 
analyzed for ash, NDF, ADF, and CP. Organic matter was calculated from ash content of 
a 0.5 g sample placed in an ashing oven (500º C) for 8 h.  Fiber content was estimated 
using an ANKOM 200 Fiber Analyzer (ANKOM Technologies, Inc., Macedon, NY). 
Crude protein values were derived using Dumas combustion (Rapid-N-Cube, Elementar 
America, Inc., Mt. Laurel, N.J.). 
Calves were monitored once daily for health status using a 5-point clinical illness 
score. Morbidity signs including depression, ocular and nasal discharges, and respiratory 
issues were pulled for temperature reading. A rectal temperature ≥ 40º C warranted 
treatment by antibiotic according to label instructions and visually severe symptoms 
resulted in treatment regardless of temperature. Description of clinical illness score 
criteria is provided in Table 28. Steers exhibiting morbidity were treated initially with 
entrofloxacin (Baytril 100, Bayer Corporation, Shawnee, MI) at a rate of 10 mg/kg BW. 
Steers requiring a follow up treatment were administered tulathromycin (Draxxin, Pfizer 
Animal Health, Madison, NJ). Bloat was quantified with a 4-point scoring system which 
followed Paisley and Horn (1998). Values were: 0 = normal, 1 = slight distention, 2 = 
distention with rumen elevated toward backline, and 3 = severe distention with rumen at 
or above back level.    
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Table 28. Descriptive criteria for subjective health evaluation 
Score Description 
0 Normal. No clinical sign of illness. 
1 Mildly abnormal respiration. Dyspnea with minor depression, gauntness, nasal 
and/or ocular discharges.  
2 Moderatley abnormal respiration. Dyspnea with noticeable depression 
gauntness, nasal and/or ocular discharges.  
3 Severely abnormal respiration. Pronounced dyspnea, depression, gauntness, 
nasal and/or ocular discharges. 
4 Moribound – immobile. 
 
 
 
 
Weight and ADG were analyzed using the mixed model (PROC MIXED) 
procedure in SAS (SAS Inst. Inc., Cary, NC). Monensin, metaphylaxis, and implant 
served as fixed effects with paddock replicate as a random effect. Forage availability and 
nutrient content were analyzed using repeated measures with compound symmetry as the 
covariance structure.  
Supplement intake was used in the 1996 NRC model to estimate forage intake. 
Body weights used in the model were means of d 0 and d 98 for each dietary treatment 
group. Measures of cumulative ADG for diet × implant were used with mean intakes of 
both diets to calculate differences in energy associated with dietary treatment by 
adjusting forage intake to meet ADG. Difference in estimated NEg by removal of 
supplement intake was attributed to supplement.  
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 Results and discussion 
Initial weight 
A by-treatment summary of initial BW, final BW, cumulative ADG, and ADG 
within each period is provided in Table 29. Initial BW (d 0) was not affected by dietary 
treatment (P < 0.28) or either of the subplot treatments (implant, P < 0.68; metaphylaxis, 
P < 0.38). Additionally, no interactions were significant with measures of initial BW 
(diet × implant, P < 0.25; diet × metaphylaxis, P < 0.98; implant × metaphylaxis, P < 
0.86; diet × implant × metaphylaxis, P < 0.61). Interactions are summarized in Table 30. 
ADG within period 
Weight gain during the first 28 d period was influenced by both implant (P < 
0.02) and metaphylaxis (P < 0.05). Daily gains were increased by 20.46% in steers 
receiving implant and 16.41% in steers given metaphylactic treatment. No difference 
was attributed to dietary treatment or any treatment interactions.  
 From d 29 through 56, implant use was effective (P < 0.01) in raising ADG. 
Metaphylactic application did not significantly increase gains (P < 0.71) though a slight 
interaction was observed between dietary treatment and metaphylaxis (P < 0.08). Diet 
alone did not influence gains nor were did any other interactions.  
 Gains during d 57 through 84 were higher in implanted cattle (P < 0.01) and an 
interaction between diet and implant was also detected (P < 0.01). Diet alone tended to 
influence gains (P < 0.11) with cattle receiving RUM having 9.33% higher gains. 
Metaphylaxis and other interactions did not significantly affect ADG. 
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Table 29. Mean BW and ADG by treatment of steers grazing winter oats  
 Diet  Implant  Metaphylaxis 
Item1 CON2 RUM3 SEM P-value  04 I5 SEM P-value  PT6 MM7 SEM P-value 
BW0 233.96 245.50 6.81 .28  240.67 238.80 5.31 .68  237.78 241.69 5.31 .38 
BW98 373.00 378.10 6.69 .61  368.64 382.46 5.68 .03  372.00 379.09 5.68 .26 
ADG28 0.98 0.91 0.08 .55  0.86 1.04 0.07 .02  0.88 1.02 0.07 .05 
ADG56 1.49 1.44 0.10 .72  1.39 1.54 0.08 .01  1.48 1.45 0.08 .71 
ADG84 1.36 1.49 0.05 .11  1.33 1.52 0.04 .01  1.39 1.45 0.04 .32 
ADG98 1.60 1.20 0.07 .01  1.32 1.48 0.06 .03  1.41 1.57 0.09 .74 
CUM56 1.24 1.17 0.03 .22  1.12 1.29 0.03 .01  1.18 1.24 0.03 .19 
CUM84 1.28 1.28 0.03 .99  1.19 1.37 0.03 .01  1.25 1.31 0.03 .09 
CUM98   1.34 1.26 0.03 .13  1.22 1.38 0.03 .01  1.28 1.32 0.03 .15 
1BW0 = initial BW, BW98 = final BW, ADG28 = ADG d 1-28, ADG56 = ADG d 29-56, ADG84 = ADG d 57-84, ADG98 = ADG d 85-98, 
CUM56 = ADG d 1-56, CUM84 = ADG d 1-84, CUM98 = ADG d 1-98 
2,3CON = Control, RUM = Rumensin containing (135 mg·hd-1·d-1) 
4,5PT = pull and treat (no metaphylaxis), MM = metaphylaxis (Micotil 300, 1.5 ml/100 kg BW)  
6,70 = no implant, I = single dose implant (TEG + Tylan) 
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Table 30. Mean BW and ADG by treatment interactions of steers grazing winter oats (kg) 
 Diet1   
 CON 
 
RUM   
 PT2  MM3 PT  MM   
Item6 04 I5  0 I 0 I  0 I SEM P, D*M*I7 
BW0 231.83 232.09  232.77 239.17  246.38 240.81  251.71 243.13 8.82 .68 
BW98 359.12 379.81  368.39 384.68  369.75 379.33  377.29 386.01 10.25 .89 
ADG28 0.71 1.03  1.12 1.09  0.77 1.00  0.85 1.03 0.12 .32 
ADG56 1.60 1.51  1.31 1.54  1.29 1.50  1.35 1.61 0.12 .28 
ADG84 1.10 1.51  1.26 1.57  1.52 1.45  1.43 1.54 0.09 .20 
ADG98 1.50 1.63  1.54 1.74  1.11 1.33  1.15 1.23 0.11 .43 
CUM56 1.15 1.27  1.21 1.32  1.03 1.25  1.10 1.32 0.07 .94 
CUM84 1.13 1.35  1.23 1.40  1.19 1.31  1.21 1.39 0.05 .46 
CUM98 1.21 1.41  1.29 1.44  1.18 1.32  1.20 1.36 0.05 .62 
1CON = Control, RUM = Rumensin containing (149 mg/kg d 1-35, 144 mg/kg d 36-105) 
2,3PT = pull and treat (no metaphylaxis), MM = metaphylaxis (Micotil 300, 1.5 ml/100 kg BW) 
4,50 = no implant, I = single dose implant (TEG + Tylan) 
6BW0 = initial BW, BW98 = final BW, ADG28 = ADG d 1-28, ADG56 = ADG d 29-56, ADG84 = ADG d 57-84, ADG98 = ADG d 85-98, 
CUM56 = ADG d 1-56, CUM84 = ADG d 1-84, CUM98 = ADG d 1-98 
7D*M*I = Diet × metaphylaxis × implant 
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Day 85 to 98 ADG were influenced by diet (P < 0.01) and implant (P < 0.03). 
Steers consuming CON gained 33.28% more than steers fed monensin whereas 
implanted steers had higher gains by 49.14%.  
Cumulative ADG by period  
Through d 56, significant differences in ADG were again attributed to use of 
implant (P < 0.01) where steers receiving treatment had gains 14.65% higher than those 
not receiving implant. Influence of metaphylaxis was not detected (P < 0.19) though 
treated steers gained 5.28% more weight. Again, no differences in ADG in the period 
were attributed to dietary treatment or treatment interactions.  
At d 84, cumulative rate of gain was again improved by implant (P < 0.01). 
Steers receiving the treatment gained 1.365 kg/d as opposed to 1.192 kg/d. Metaphylaxis 
tended to increase ADG (P < 0.09) by increasing gains 4.88%. No differences were 
observed as a result of supplement or interactions of treatments.  
Encompassing the entire trial, use of implants improved ADG by 13.46% (P < 
0.01). Gains were slightly affected (P < 0.13) by dietary treatment as steers assigned 
CON supplement gained 28.08% more weight. Metaphylactic usage also increased gains 
(P < 0.15; 16.65%). No treatment interactions were detected. Gains of cattle receiving 
metaphylactic were 16% higher during the first 28 days on pasture and tended to be 
slightly higher during days 0 to 84 and 0 to 98. Initial gain differences are nearly 
identical to those provided in a summary by Wileman et al., 2009. Galyean et al. (1995) 
observed no difference in ADG among steers treated with tilmicosin or a control in an 
initial 56 day feeding period; however, a significant reduction in cattle pulled for bovine 
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respiratory disease was achieved. Herd health in our study was excellent and void of any 
necessary treatment associated with internal abnormalities. Part of this stability may be 
attributed to common origin of the cattle. Influence on ADG during the later periods are 
somewhat unexpected in that most problems associated with bovine respiratory disease 
and associated performance reductions are manifested within the first 45 of arrival 
(Edwards, 1996). However, reviewed temporal patterns of outbreaks in feedlots suggest 
that occurrence may be delayed (Babcock et al., 2009). Despite occasional late 
occurrences, treatment is most effective as it relates to ADG when provided on arrival as 
opposed to delay (Kreikemeier et al., 1996). 
Implanting steers provided the most consistent impact among treatments in this 
trial. Final body weight as well as all ADG measures both within period and cumulative 
were significantly increased as a result of implantation. Mean increases in ADG among 
all measures in this study were 0.17 kg/d. These results are substantially higher than 
approximate reported ranges of cattle on small grains (0.08 kg/d, McCollum, 2006).  
Gains relative to control from this study were identical to steers fed a distillers’ grain 
supplement in a split-plot design (mean = 0.17 kg/d, McMurphy et al., 2009) evaluating 
implant type though gain response in regards to implant assignment was undefined. 
Interactions in this study were largely insignificant as expected due to unrelated modes 
of action among between treatments.   
Supplement intake 
Mean DMI of dietary treatments were different overall (P < 0.01) with steers 
assigned RUM consuming less than CON (0.26 vs. 0.56 kg·hd-1·d-1, respectively). 
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Within dietary treatments, supplement DMI was not different among paddocks (RUM, P 
= 0.28; CON, P = 0.91). Overall, supplement containing monensin in this study was 
consumed at a considerably reduced rate relative to a control. Intakes were reduced 54% 
by an inclusion rate similar to that of Paisley and Horn (1996) who observed intake 
reductions of 43%. As an expected result of reduced means, coefficient of variation for 
weekly supplement intake was much higher in this study for supplement containing 
monensin compared to a control diet. Though intakes of a monensin-containing 
supplement were slightly higher, calculated coefficient of variation was much lower in 
the data published by Paisley and Horn (1996) and much closer to control diet variation 
measures. 
Final weight 
Ending BW (d 98) was significantly influenced by use of implant (P < 0.03). 
Body weights were increased by a mean of 13.82 kg relative to non-implanted steers. 
Neither diet (P < 0.61) nor metaphylaxis (P < 0.26) impacted final weights and no 
interactions were detected.  
Response to supplement 
Estimation of forage intake to meet observed gains using the 1996 NRC model 
indicated that supplement containing monensin resulted in an 8.45% increase in NEg 
yield (CON = 1.42 Mcal/kg, RUM = 1.54 Mcal/kg). Estimated forage intake to meet 
actual gain in the absence of supplement was lowest for RUM -0 (4.43 kg/d) group and 
highest for CON-I (5.10 kg/d). Intake was the same for CON-0 and RUM-I (4.75 kg/d). 
Neither initial nor final BW in this study was significantly influenced by dietary 
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treatment. This suggests that steers assigned monensin either compensated by consuming 
more forage or were provided sufficient energy despite intake level to facilitate gains 
similar to other steers consuming twice as much. Average daily gains were only 
significantly influenced by diet from day 84 to day 98; however, cumulative ADG 
tended to higher in steers not consuming monensin. Typically, monensin would be 
expected to increase ADG (Horn et al., 1981). Therefore, atypical results of this study 
are attributed to low level of supplement intake. Supplemental energy will increase ADG 
on small grains pastures due to increased microbial growth and protein synthesis 
(McCollum and Horn, 1990; Horn et al., 1995). Therefore, reduced intake associated 
with monensin inclusion would be expected to reduce ADG response relative to steers 
consuming a higher level of supplement.    
Standing crop 
Over the course of the trial, forage availability was unaffected by dietary 
treatment (P = 0.52) and no dietary treatment × day interaction occurred (P = 0.26). 
Standing crop decreased from d 0 to 56 then increased through d 98 where forage mass 
peaked (6324 ± 366 kg DM/ha) resulting in a day effect (P < 0.01, Figure 16).  
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Figure 14. Standing forage (kg DM/ha) in paddocks expressed as means within 
collection date.  
 
 
Forage mass per kg BW 
 Available forage per kg BW was unaffected by diet (P = 0.38) and no interaction 
of diet × collection day was observed (P > 0.50). Forage allowance per kg BW was 
highest at beginning to trial in paddocks where RUM was fed whereas forage availability 
increased between d 0 and 56 in paddocks assigned to CON supplement. Figure 17 
depicts trend in forage availability per kg BW for both diets. 
 
4880.51 5151.2 4357.74 5898.14 6324.48 
0 
1000 
2000 
3000 
4000 
5000 
6000 
7000 
8000 
0 28 56 84 98 
k
g/
ha
 
Day 
ab b a c c 
Standing forage availibility by day (kg DM/ha)  
113 
 
 
Figure 15. Standing forage mass relative to mean BW of steers by dietary treatment.  
  
 
When forage availability is expressed on a DM basis per 100 kg of BW, diet 
tended to influence herbage mass (P < 0.18) whereas day (P < 0.01) and diet × day (P < 
0.02) both had a significant impact on availability. Again, trend in forage mass 
availability from d 0 and d 28 was antithetical between dietary treatments. Figure 18 
provides measures at each date. Density was sufficient to support maximum gain 
throughout the trial. Collectively, Pinchak et al. (1996) and Redmon et al. (1995) stated 
that ranges of herbage allowance to fully support ADG potential be maintained between 
20.0 and 27.3 kg DM/100 kg BW. At a minimum, forage density in this trial was 
calculated to exceed 160.0 kg DM/100 kg BW. 
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Figure 16. Available forage by diet and day expressed in kg DM/100 kg BW 
 
Nutrient composition 
A visual reference to nutrient trend is provided in figure 19. Nutrient content of 
paddocks are expressed as means within each collection date due an absence of diet 
effect or diet × day interaction for all measures (Table 31).  
0 28 56 84 98 
CON 166.9 556.59 163.77 269.52 437.47 
RUM 191.91 277.53 190.41 279.12 431.77 
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Figure 17. Nutritive values of paddock forage expressed as means within collection 
date.  
 
 
Dry matter, OM, NDF, ADF, and CP were all affected by day (P < 0.01).  Crude 
protein decreased from 22.7% to 8.4% over the course of the trial and was unaffected by 
diet (P = 0.99) or day × diet (P = 0.79). Proportion of fiber components increased during 
the study with no diet effect (P = 0.26 NDF, P = 0.28 ADF) or diet × day interaction (P = 
0.40 NDF, P = 0.63 ADF). 
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Table 31. Nutrient composition by day of winter oat pastures 
 d    P-value 
Item, % 0 28 56 84 98  SE  Day Diet Day × Diet 
DM 17.9 44.9 24.6 32.3 50.7  3.28  .01 .34 .34 
OM 86.3 89.0 88.5 91.3 91.2  0.35  .01 .89 .43 
NDF 40.8 42.4 45.5 51.3 55.2  0.84  .01 .86 .40 
ADF 19.3 19.4 23.6 27.2 29.4  0.45  .01 .28 .63 
CP 22.7 17.5 15.9 10.1 8.4  0.93  .01 .99 .79 
 
Both dietary treatments had lower ADG in the first period relative to the last period. This 
is contrary to expectations that ADG would decline as crude protein declines concurrent 
to increased neutral and acid detergent fiber levels. However, previous findings have 
indicated similar responses due to an initial period of reduced forage DMI associated 
with inability to process high levels of soluble N (Chalupa et al., 1964; Phillips, 1986; 
Phillips and Horn, 2008). Climatic data collected with exception of wind are provided in 
Table 32. 
 
Table 32. Weather data expressed as means within collection period 
 d 
Item 1 – 28  29 – 56  57 – 84  85 - 98 
Min temp, ºC         2.8  7.2  13.3  15.9 
Max temp, ºC       15.0  21.1  25.6  29.5 
Humidity, %       65.3  63.9  63.8  59.6 
Precipitation, cm1         7.9  0.8  1.8    0.0 
1Precipitation expressed as total accumulation within collection period. 
 
 
Conclusion 
Response to an energy supplement containing monensin did not significantly 
influence final BW or cumulative ADG of steers grazing small grains. At the only 
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significant observation, supplement void of ionophore resulted in increased gains. These 
results are not supported in a consistent manner by previous study and are attributed here 
to an inadequate level of monensin-containing supplement intake. However, modeled 
forage intake to meet gains did indicate an increased energy effect by which forage level 
necessary to achieve results in the absence of supplement was reduced. Use of 
metaphylaxis in steers at initiation of the trial improved ADG for the first 28 days of 
grazing relative to untreated steers. Use of a single dose implant was effective at 
increasing weight gain for the entire 98 day grazing period. Combinations of the 
technologies did not increase performance.  
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